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1. GENERAL INTRODUCTION 
 
In 2019 the population aged 65 years or over in Europe grew up by 2.9% 
compared to 2009, reaching a percentage of 20.3% of the EU population. 
Italy and Greece were the countries with the highest percentage of 
elderly people, respectively 22.8% and 22.0% of the population, while 
Ireland and Luxembourg had the lowest percentages: 14.1% and 14.4% 
(Eurostat, 2020). 
 





This trend is bound to increase over time, in fact a Eurostat study shows 
that people aged 65 years and over will increase from 20% in 2018 to 31% 
in 2100 (Eurostat, 2019). However, the effects of the Covid-19 outbreak 
on mortality could change this trend. Indeed, if we analyzed mortality 
data of 2020 the number of deaths across the 31 European countries 
starts to rise abruptly at the beginning of March, in week 10, compared 
to previous years (average over 2016 to 2019). In particular, weeks 10-12 
are marked by increased death for the age groups 70-79 and 80-89 and 
deaths of men rise faster than those of women every week (Eurostat, 
2020 c).  
Aging is a complex phenomenon characterized by different mechanisms. 
These mechanisms, called “seven pillars of ageing”, includes adaptation 
to stress, loss of proteostasis, stem cell exhaustion, metabolism 
derangement, macromolecular damage, epigenetic modifications, and 
inflammation (Franceschi et al., 2018; Kennedy et al., 2014).  
One of the universal features of the ageing process appears to be a 
chronic, low-grade inflammatory state called “inflammaging” (Franceschi 
et al., 2007; Cevenini et al., 2013). 
In particular, “inflammaging” is characterized by a complex reshape in the 
production of pro- and anti-inflammatory mediators, which, as a whole, 
tilts the balance toward an increase of the level of basal inflammation. As 
an example, aging is characterized by a decreased production of the anti-
inflammatory interleukin 10 (IL-10) and an increase of the pro-
inflammatory interleukin 6 (IL-6), (Marcos-Pérez et al., 2020), this one in 
particular is considered a risk factor for many of the major age-associated 
diseases, including obesity, cardiovascular diseases, sarcopenia and 
frailty (Santoro et al., 2020). 
In addition, there is an association between changes in body composition 




(LM) that is referred to as sarcopenia, and an increase of fat mass (FM) 
(Zong et al., 2017). These modifications of BC have likely a large impact of 
the health status and inflammaging in particular, as FM, and visceral fat 
in particular, is an important source of pro-inflammatory cytokines, 
produced by both the adipose tissue itself (adipokines) and the infiltrating 
macrophages and lymphocytes (Mancuso et al., 2016). Though BMI has 
always been considered a valid tool to assess overall adiposity, when it is 
necessary to investigate the distribution of body fat associated with 
chronic diseases and mortality it doesn’t provide the right support. 
(Prentice and Jebb, 2001; Zong et al., 2017; Carmienke et al., 2013). 
Therefore, it is necessary to use tools that can correctly, safely and quickly 
evaluate the BC. There are different methods to measure BC such as 
computed tomography, magnetic resonance imaging, dual-energy X-ray 
absorptiometry and ultrasound (Ponti et al., 2020). The reference method 
is Dual-energy X-ray Absorptiometry (DXA), which is considered the most 
developed and tested technique for the evaluation of BC bone mineral 
density (BMD) (Bazzocchi et al., 2013; Guglielmi et al., 2016). Moreover, 
DXA can assess three body-composition components at a molecular level: 
bone mineral content (BMC), lean mass (LM) and fat mass (FM) and it is 
possible to measure the amount of visceral adipose tissue (VAT) and 
subcutaneous adipose tissue (SAT) in addition of total-body and standard 
regional body composition measures (Ponti et al., 2020). A systemic study 
on the age-related changes in BC was missing, as well as the connections 
between these changes and parameters linked to inflammaging and 
overall health. 
In a variable percentage of elderly people, a condition of decreased 
capability to cope with and recover from stresses even of mild intensity 
is present. This condition, indicated as frailty, is a strong predictor of 
disability, hospitalization and mortality and a criterion for non-eligibility 




different approaches, using either phenotypical or functional 
components (Morley et al., 2013). Indeed, frailty can be identified 
according to a standardized phenotype described by Fried and colleagues 
(Fried LP et al., 2001) by verifying if three or more of the following criteria 
are met: involuntary weight loss, exhaustion, low physical activity, low 
gait speed, and low grip strength. Accordingly, people can be divided in 
three different groups: non-frail (none of these criteria are met), pre-frail 
(one or two features are met) and frail (three or more criteria are met). 
Furthermore, it has been demonstrated that an elevated waist 
circumference and body fat mass are risk factors for frailty in the elderly 
(Xu Et al., 2020). Also in this case, the connections between BC and frail 
status are largely unexplored, with particular regards for parameters 
related to inflammaging. In order to perform large scale analyses 
regarding these connections, a large dataset is needed, that must be 
interrogated with appropriate techniques of advanced statistics in order 
to grasp the complexity of the phenomenon. To this aim, we exploited 
the dataset of two research projects run in the laboratory where I did my 
PhD work: the NU-AGE and the PROAGE projects.  
Within the framework of the European NU-AGE project – New dietary 
strategies addressing the specific needs of elderly population for a 
healthy ageing in Europe (Grant Agreement no. 266486, Coordinator 
Prof. Claudio Franceschi, registered at clinicaltrials.gov as NCT01754012) 
- non-frail and pre-frail volunteers were selected using the standardized 
phenotype scale proposed by Fried et al., and a DXA scan has been carried 
out as well. In this project 1,250 free-living elderly people, aged between 
65 and 79 y.o., free of major diseases, were enrolled within five European 
centers (Italy, France, United Kingdom, Netherlands and Poland). All 
volunteers underwent multiple specific tests and laboratory analysis to 
accurately assess their general health, physical and cognitive functioning 




nutritional intervention (T0) and after 12 months (T1), allowing to collect 
in the project database over 2,000 parameters (Santoro et al., 2014). A 
large amount of data has also been collected on the composition and 
functionality of intestinal flora, immune system, genetic and epigenetic, 
transcriptomic and metabolomic. 
The presence of frailty was one of the exclusion criteria in the NU-AGE 
project, as the aim was to include healthy elderly (Berendsen et al., 2014). 
So, in collaboration with the Nestlé Institute of Health Sciences (NIHS) 
from Lausanne (Switzerland), one of the partners of the NU-AGE study, a 
new project has been defined and funded to recruit frail subjects, named 
PRO-AGE: “Omics for Aging-ProAGE” (n. 14.02. NIHS Code NPDI n. DUND-
100373). As reported in Figure 1.2, PRO-AGE uses the same protocol as 
NU-AGE for the recruitment of subjects, the age is between 65 and 79 
years and it has been run in Italy (Bologna). Again, frailty has been 
assessed with the presence of at least 3, or more, of the parameters 
proposed by Fried et al. and the same measurements of NU-AGE were 
carried out at T0 and after a follow up of 12 months in each of the 23 
recruited subjects with the exception of the nutritional trial that has not 










2. AIMS OF THE STUDY 
 
The main aim of my PhD work was to analyze the connections between 
BC parameters, hematochemical and biochemical parameters with a 
special focus on inflammaging on a large population sample of elderly 
people with or without frailty. To do this, I made use of innovative 
statistical methods to analyze the data collected in the NU-AGE and 
PROAGE projects. 
In particular I focused on answering these three scientific questions: 
 Is body composition in elderly across Europe different? Are there 
Body composition differences by sex? 
 Which are the inflammatory and metabolic markers associated 
with body composition in the elderly? 
 Which are the main differences of body composition and health 
markers that characterize frail individuals? Is there a BC “frailty 
signature”? 
These three questions have generated the results of my PhD thesis that 
will be presented and discussed in the following three Chapters. The first 
two Chapters regard data that have already been reported in publications 
in international journals that I co-authored, while the latter reports on 
still unpublished data.  
It is well known that accumulation of fat causes serious medical 
complications, and the prevalence of many of this were associated with 
obesity, such as hypertension, diabetes, cardiovascular diseases which 
increases with age. The aim of the first study (Santoro et al., 2018a) was 
to evaluate the BC assessed by DXA in 1,250 healthy elderly to investigate 




Unsupervised Machine Learning technique, i.e. Hierarchical Cluster 
Analysis, to define specific BC profiles specific for males and females. 
It has been reported that an increase in fat mass is correlated with 
markers of inflammation among elderly (Brinkley et al., 2018; Schrager et 
al., 2007). Nevertheless, not so many studies on the correlation between 
inflammatory parameters and the distribution of fat, lean and bone mass 
are available. The aim of the second study (Santoro et al., 2018 b) was to 
assessed the correlations of those BC parameters with several 
inflammatory and adipose related parameters. 
As mentioned the presence of frailty has been assessed using the 
standard phenotype scale described by Fried et al. even if other 
diagnostic criteria are proposed, such as Frailty Index by Rockwood. 
Despite the Fried et al. scale is the most used, the presence of some 
components of this phenotype, i.e. low hand grip strength or low gait 
speed, are more relevant than others.  
This may affect the correct detection of the pre-frail subject, in fact a 
systematic review by Fernandez-Garrido et al. (2014) show that the 
prevalence of pre-frailty can change in different cohorts of people aged 
over 65, ranging between 35 and 60%. The aim of the third study was to 
detect differences of body composition and health markers that 
characterize pre-frail or frail individuals. In addition, through regression 





3. BODY COMPOSITION IN ELDERLY ACROSS EUROPE 
 
This Chapter regard data that have already been reported in publication 
A Cross-Sectional Analysis of Body Composition Among Healthy Elderly 
From the European NU-AGE Study: Sex and Country Specific Features 
(Santoro et al., 2018a). 
 
3.1 INTRODUCTION 
As mentioned in the general introduction, there is an association 
between changes in BC and aging. In general, this association is 
characterized by a decrease in subcutaneous FM, while visceral fat and 
muscle fat infiltration tend to increase with age. Since the BC is associated 
with several diseases and decline in health status, monitoring weight 
among older adults becomes very important. In addition, weight gain, 
weight cycling and in particular weight loss are associated with higher 
mortality risk (Cheng FW et al., 2015). However, this changes in total FM 
and LM are often independent from changes in weight and therefore not 
detectable using body mass index (BMI). In fact, this tool doesn’t provide 
the right support when it is necessary to investigate the distribution of 
individuals’ body fat contents (Prentice AM, 2001; Zong et al., 2017). 
Several studies related to BC have shown that, independently of BMI 
levels, trunk fat has been linked to metabolic abnormalities (Bjorntorp, 
1991; Bosy-Westphal et al., 2015), and visceral and neck adipose tissue 
are related to incidence of cardiovascular diseases (Arsenault et al., 2012; 
Britton et al., 2013; Torriani et al., 2014). Moreover, there is evidence that 
in older populations there is an association between improved physical 
function and the preservation of lean muscle mass with scarce muscle fat 




while increase in  muscle fat infiltration is associated with higher mortality 
risk (Miljkovic et al., 2015; Reinders, Murphy, Brouwer, et al., 2015). Thus, 
the attention of clinicians to study the BC has increased. Due to its 
relatively low cost, fast acquisition time and low radiation exposure, as 
compared to other available techniques, DXA is considered the gold 
standard for the assessment of human BC (Alberto Bazzocchi et al., 2013; 
Guglielmi et al., 2016). 
As mentioned, DXA can assess three body-composition components at a 
molecular level: BMC, LM, and FM in addition of BMD. Moreover, DXA 
allows to measure total-body and standard regional body composition, 





Figure 3.1 | A. Skeletal map of whole-body scan by Dual-energy X-Ray absorptiometry 
(DXA) (head—H, trunk—T, upper limbs—U, lower limbs—L, gynoid—G, and android—
A). B. Represents the soft tissue maps of whole body DXA scan from fat mass, yellow, to 
bone mass, blue in old females. (Modified from Ponti et al., 2020) 
 
There are significant differences in BC between countries, genders and 
human populations (Hinton et al., 2017; Kelly et al., 2009) and since there 
are several methods to assess BC, indexes and measures have been 
proposed to evaluate differences among healthy and unhealthy 
populations (A Bazzocchi et al., 2016). DXA measures of adiposity and 
muscle mass include fat mass index (FMI: total FM/height2); visceral 




gynoid FM ratio (A/G FM), trunk to leg fat mass ratio (T/L FM); lean mass 
index (LMI: total LM/height2); appendicular lean mass (ALM: arms LM + 
legs LM) and the corresponding indexes standardized to height and 
weight called appendicular lean mass index (ALMI: ALM/ height2) and 
skeletal muscle mass index (SMI: ALM/total weight) respectively (Petak 
et al., 2013).  
A systemic study on the age-related changes in BC was missing and, to 
the best of our knowledge, no study to date has evaluated BC parameters 
by DXA scan among elderly populations in Europe.  
Within the framework of the NU-AGE project a whole-body DXA scan has 
been carried out in 1121 gender-balanced free-living, apparently healthy 
older adults aged 65 to 79 years enrolled in 5 European Countries (Italy, 
France, United Kingdom, the Netherlands, and Poland) (Santoro et al., 
2014). As reported in the “Aims of the studies” section, in the current 
study we evaluate the BC assessed by DXA to investigate country- and 
gender-related differences. In addition, we used Unsupervised Machine 








Study design and population 
NU-AGE (http://www.nu-age.eu/) is a one-year, multicenter, 
randomized, single-blind, controlled trial (registered with 
clinicaltrials.gov, NCT01754012) carried out in five European centers 
located in France (Clermont-Ferrand), Italy (Bologna), the Netherlands 
(Wageningen), Poland (Warsaw), and the United Kingdom (UK, Norwich) 
(Santoro et al., 2014). The recruitment of participants has been described 
in detail previously (Berendsen et al., 2014; Santoro et al., 2014). 
Originally, 2668 man and women volunteers from the community aged 
65–79 years, free of major overt chronic diseases compromising 2-year 
survival (i.e., cancer, dementia), free and independent living, and 
competent to make own decisions, were recruited from July 2012 to 
January 2014 to participate in the baseline assessment. After testing the 
exclusion criteria, i.e. included severe heart diseases, type 1 and insulin-
treated type 2 diabetes, chronic use of corticosteroids, recent use of 
antibiotics or vaccinations, change in habitual medication use, presence 
of frailty (Fried et al., 2001), malnutrition (body mass index <18.5 kg/m2 
or 10% weight loss within 6 months), or food allergy/intolerance requiring 
special diets, 1296 were eligible to participate in the NU-AGE trial. 
Complete DXA scan was performed in 1121 participants, at baseline, and 
were included from the NU-AGE study cohort. According to the 
Declaration of Helsinki, all participants signed the informed consent 
before their inclusion in the study. NU-AGE was approved by the Ethics 
Committee of the coordinator center: the Independent Ethics Committee 
of the S. Orsola-Malpighi Hospital Bologna (Italy), and by the 
local/national Ethics Committees of all the other four recruiting centers: 
the South-East 6 Person Protection Committee (France), the Wageningen 




Research Ethics Committee–East of England (UK), and the Bioethics 
Committee of the Polish National Food and Nutrition Institute (Poland).  
 
Assessment of Body Composition 
A whole-body DXA scan has been carried out to measure total and 
regional BC using the following fan-beam densitometers in each of the 
five recruiting centre: Discovery QDR, Hologic Inc., Bedford, MA, USA – 
software version 3 (Clermont-Ferrand, France); Lunar iDXA, GE 
Healthcare, Madison, WI, USA – enCORETM 2011 software version 13.6 
(Bologna, Italy); Lunar Prodigy, GE Healthcare, Madison, WI, USA – 
enCORETM 2011 software version 13.6 (Wageningen, the Netherlands 
and Warsaw, Poland); and Discovery Wi, Hologic Inc., Bedford, MA, USA 
(Norwich, UK). The scanners were calibrated daily using a standard 
calibration block supplied by the manufacturers following standard 
Quality Control procedures. DXA scans were performed by trained 
technicians according to state-of-the-art technique and manufacturers 
recommendation. No metal items were present during densitometry. 
Participants were positioned in the center of the scanning field in a supine 
position with the arms at sides and separated from the trunk. As 
mentioned, measurements of total-body and standard regional body 
composition, such as trunk, upper limbs, android and gynoid region were 
defined by DXA. In the UK, android and gynoid regions were not detected 
by the densitometer. The weight (in g) of total mass, whole body fat mass 
(FM), non-bone whole body lean mass (LM), and bone mineral content 
(BMC), was scanned. In order to reduce the possible error generated by 











Whole body fat mass/ whole body lean 
mass 
b fat mass index (FMI) Whole body fat mass/ heigth2 
c 
Lean Mass index 
(LMI) 
Whole body lean mass/ heigth2 
d android/gynoid FM Android fat mass/ gynoid fat mass 
e android FM/LM Android fat mass/ android lean mass 
f 
Appendicular Lean 
Mass index (ALMI) 
Lean mass from arms plus legs/height2 
g 
skeletal mass index 
(SMI) 
Lean mass from arms plus legs/weight 
Table 3.1 | Pivotal markers of BC 
The indexes of total body FM/LM, FMI, and LMI are considered markers 
of general mass, android/gynoid FM is related of central/peripheral 
distribution of FM, while the FM/LM android, and ALMI and SMI indices 
are markers of central abdominal distribution, low muscle mass 
respectively. Moreover, bone mineral density (BMD) and T-score were 
also considered as markers of bone health. 
 
Data collection  
An adherence scoring on the NU-AGE Diet was created with cut-off values 
based on the NU-AGE Food Based Dietary guidelines (Berendsen et al., 
2018). The NU-AGE index is a 160-point scale that includes minimum 
consumption recommendations for fruits, vegetables, legumes, low-fat 
dairy products, low-fat cheese, fish, low-fat meat and poultry, nuts, olive 
oil, liquids and vitamin D3 (from a supplement), minimum and maximum 
intake frequencies, for whole grains and eggs, and recommendations to 




the NU-AGE index in a percentage scale ranged between 0, no adherence, 
and 100, fully adherent. 
Data on educational level (level and years), physical activity (Physical 
activity scale for the elderly, PASE (Washburn et al., 1993), and medical 
history (use of drugs for hypertension [yes/no], use of drugs for diabetes 
[yes/no], use of drugs for hypercholesterolemia [yes/no], use of vitamin 
D supplementation [yes/no], use of calcium supplementation [yes/no]) 
were obtained by means of questionnaires. Height was measured with a 
stadiometer to the nearest 0.1 cm. Weight was measured to the nearest 
0.1 kg with a calibrated scale while wearing light clothes. Body Mass Index 
(BMI) was calculated as weight [kg]/height[m]2. Calorie intake was 
calculated by mean of the 7days food record completed by the 
participants at baseline. Handgrip strength test was performed by 
standardized procedures using Jamar handheld dynamometer. Blood 
pressure was measured using automated and calibrated electronic blood 
pressure monitors. All measures were taken by trained research 
assistants. 
Glycated haemoglobin was measured on fresh blood in each recruiting 
centres by standard methods. Plasma total, HDL and LDL cholesterol 
(mg/dL) and triglycerides (mg/dL) were measured on a konelab system 
and reagents were from Thermo Scientific (Asnières sur Seine, France). 
Concentrations of total 25-hydroxyvitamin D (25(OH)D) [i.e. 25(OH)D2 
plus 25(OH)D3] and parathyroid hormone (PTH) in all serum samples 
were measured at the laboratory of the Cork Centre for Vitamin D and 
Nutrition Research. 25(OH)D was measured by a modified version of the 
LC-MS/MS method that has been described in detail elsewhere (Cashman 
et al., 2013) and is certified by the Centers for Disease Control and 
Prevention’s (CDC) Vitamin D Standardization Certification Program 
(VDSCP: List of Certified Participants, 2018). PTH was measured with an 




CVs were 3.0% and 5.1%, respectively (at a concentration of 47.7 and 52.6 
pg/ml, respectively). All the other biochemical analyses glucose (mmol/L), 
insulin (mcU/mL), albumin (g/L), and creatinine (mmol/L), were 
measured on frozen blood and frozen urine (urea) in a centralized centre 
with standard methodologies. 
 
Statistical Methods 
After testing the data distribution, according to Shapiro-Wilk test for 
Normality (p < 0.01) we decided to use non-parametric statistical tests. R 
studio (Version ‘1.0.136’ for Windows) was used as analysis’ tool and 
results are reported as mean and standard deviation (± SD). Data were 
analyzed by non-parametric statistical tests, i.e. Mann - Whitney and 
Kruskal - Wallis tests, to determinate differences between males and 
females and between the five countries, respectively. To test differences 
between all pairs of country a pairwise comparison was used. A type I 
error of 0.05 (p-value) in two-tailed tests was considered significant. The 
Benjamini–Hochberg correction was applied (q-value) in order to reduce 
the error due to multiple testing of the variables. Furthermore, we 
decided to perform an unsupervised machine learning technique, i.e. 
hierarchical cluster analysis, to detect different groups based on Body 
Composition's parameters. We used this method instead of k-means 
analysis because the desired number of groups was not defined a priori. 
Indeed, this method constructs a hierarchy of nested clusters which does 
not require cluster number specification (Chalise et al., 2014). Several 
studies have shown differences between Males and females in BC (Hinton 








Table 3.2 shows anthropometric, physical, nutritional and body 
composition characteristics of NU-AGE study participants by gender. 
Differences among 620 Female (55%) and 501 Males (45%) are significant 
for anthropometric measures, diet assessment, physical functioning and 
BC parameters while there are no differences in education. So, males and 
female were separately investigated in this analysis. Regarding 
anthropometrics characteristics males are taller than female, and have 
higher weight, BMI, waist circumference and waist to hip ratio. On the 
other hand, males show grater physical activity (PASE score) and strength 
(handgrip strength) together with higher calorie intake. BC parameters 
highlight a higher presence of fat mass markers in female with significant 
differences compared to males in terms of FM, FMI, FM/LM and android 
FM/LM but lower android/gynoid FM, males have significantly higher 
lean mass markers than females in terms of LM, ALMI, LMI, SMI and also 
higher bone content markers in terms of BMC, BMD, T-score, L1-L4 T-
score, L1—L4 BMD, neck T-score and neck BMD than females. 
1121 NU-AGE participants’ characteristics were separately investigated 
according to country of origin: Italy (n = 236), Poland (n = 222), UK (n = 
246), France (n = 184) and The Netherlands (n = 233). Table 3.3 shows 
anthropometric, physical, nutritional and body composition 
characteristics of NU-AGE study participants by country. Significant 
differences among country emerged, in particular French subjects have 
the lowest values in terms of weight, BMI, hip and waist circumference 
then other countries, while Polish subjects have the highest ones, with 
the exception of hip circumference that is higher in English subjects. 
Moreover, French subjects have the highest adherence to the NU-AGE 
diet at baseline and the highest calorie intake, while the lowest 




and Italian subjects, respectively. English subjects have the highest 
handgrip strength value, in both Males and Females, and PASE score, 
while Polish subjects and Italian subjects have the lowest handgrip 
strength and the lowest PASE score, respectively. BC parameters highlight 
significant differences in terms of FM, FMI, FM/LM and android FM/LM 
with highest values reported in Polish subjects and lowest values in 
French subjects. In fact, French subjects have higher lean mass markers, 
i.e. LM, ALMI, LMI and SMI, unlike the Italian and Polish subjects who 
have the lowest ones. Regarding bone mass, the highest values are 
reported in Dutch subjects (BMC, T-score and BMD) and the lowest ones 
in English subjects (L1-L4 BMD and neck BMD). Given the differences 
between Female and Male (Table 3.2) we have analyzed the differences 
between countries by gender 
 
Cluster Analysis 
In order to answer the question defined in the section “aims of the 
studies” and define a specific BC profiles among the participants a cluster 
analysis was performed. Males (n = 501) and females (n = 620) profiles 
were separately investigated using the following ten BC markers: FM, 
FMI, LM, LMI, ALMI, FM/LM, SMI, t-score, BMC and BMD in addition to 
BMI. The hierarchical cluster analysis identified five clusters for females 
and six clusters for males. According to the mean value of BMI we named 
these clusters as: Normal Weight (NW; BMI= 21.4 kg/m2; N=89), 
Overweight A (OWA; BMI= 25.1 kg/m2; N=251), Overweight B (OWB; 
BMI= 26.6 kg/m2; N=137), Low Obesity A (LOA; BMI= 31.5 kg/m2; N=61), 
and Low Obesity B (LOB; BMI= 31.9 kg/m2; N=82) in females (Table 3.4 
A) and Normal Weight (NW; BMI= 24.0 kg/m2; N=122), Overweight A 
(OWA; BMI= 25.7 kg/m2; N=20), Overweight B (OWB; BMI= 26.3 kg/m2; 




(LOB; BMI= 30.4 kg/m2; N=80) and Moderate Obesity (MO; BMI= 35.5 
kg/m2; N=12) in males (Table 3.4 B).  
The distribution of female within the five cluster is divided as follow: 
40.5% in OWA and 22,1% in OWB, NW represents the 14.4%, LOA 9.8% 
and LOB 13.2 %. In these groups the increase of BMI coincides with an 
increase in fat mass, in terms of FM, FMI and FM/LM markers, on the 
contrary no correlation with lean and bone masses emerged. Comparing 
clusters with similar BMI, such as OWA (BMI= 25.1 kg/m2) and OWB 
(BMI= 26.6 kg/m2) and LOA (BMI= 31.5 kg/m2) and LOB (BMI= 31.9 
kg/m2), a different distribution of BC emerged. Particularly, evaluating 
differences among the two overweight groups, OWA with respect to OWB 
have lower fat mass in terms of FM (23.8 vs 26.9 kg; p=3.1e-08), FMI (9.2 
vs 10.9 kg/m2; p=4.0e-14) and FM/LM (0.6 vs 0.7; p<2e-16), but higher 
lean mass in terms of LM (40.4 vs 37.2 kg; p=2.7e-11), LMI (15.5 vs 15.1 
kg/m2, p=0.00075) and SMI (0.3 vs 0.2; p=4.0e-11) and bone mass in 
terms of T score (-0,4 vs -1.9; p<2e-16), BMC (2190.4 vs 1804.1 g; p<2e-
16) and BMD (1.1 vs 0.9 g/cm2; p<2e-16). Comparing the two low obesity 
groups, LOA with respect to LOB have lower fat mass in terms of FM (32.7 
vs 38.5; p=7.7e-08), FMI (12.9 vs 14.9; p=1.5e-06) and FM/LM (0.7 vs 0.9; 
p<5.8e-16) and bone mass in terms of T score (-0.6 vs 0.2; p=1.3e-05), 
BMC (2133.4 vs 2454.4; p=3.2e-08) and BMD (1.05 vs 1.13; p=4.7e-07), 
but higher lean mass in terms of LM (47.1 vs 42.1; p=4.4e-07), LMI (18.6 
vs 16.2; p=2.3e-16), ALMI (8.0 vs 6.8; p<2e-16) and SMI (0.25 vs 0.21; 
p<2e-16) (Table 3.4 A). 
The distribution of males within the six cluster is divided as follow: the 
46.5% in OWB and 24.3 % in NW, while OWA represents the 4.0%, LOA 
6.8%, LOB 16.0 % and MO 2.4%. 
As shown for female, also in male subjects the increase of BMI coincides 
with an increase in fat mass, in terms of FM, FMI and FM/LM markers, 




Moreover, clusters with similar BMI such as OWA (BMI= 25.7 kg/m2) and 
OWB (BMI=26.3 kg/m2) and LOA (BMI= 30.1 kg/m2) and LOB (BMI= 30.4 
kg/m2) have a very different distribution of BC. Comparing the two 
overweight groups, OWA with respect to OWB have lower fat mass in 
terms of FM (15.6 vs 22.2 kg; p=7.6e-06), FMI (5.1 vs 7.5 kg/m2; p=1.3e-
06) and FM/LM (0.2 vs 0.4; p=2.7e-10), but higher lean mass in terms of 
LM (61.8 vs 54.0 kg; p=3.9e-06), LMI (20.3 vs 18.2 kg/m2; p=8.2e-08), 
ALMI (9.1 vs 8.1 kg/m2; p=1.1e-07) and SMI (0.4 vs 0.3; p=4.0e-09) and 
bone mass in terms of T score (1.9 vs -0.4; p=4.1e-13), BMC (3576.2 vs 
2891.4 g; p=4.4e-09) and BMD (1.4 vs 1.2 g/cm2; p=4.7e-13). Comparing 
the two low obesity groups, LOA with respect to LOB have lower fat mass 
in terms of FM (23.3 vs 31.5 kg; p=3.0e-09), FMI (7.8 vs 10.3 kg/m2; 
p=2.2e-07) and FM/LM (0.4 vs 0.5; p=9.8e-14) and bone mass in terms of 
T-score (-0.5 vs 0.7; p=1.4e-07) and BMC (2791.9 vs 3391.6 g; p=1.0e-09) 
but higher and BMD (1.6 vs 1.3; p=8.2e-07) and lean mass in terms of LM 
(65.8 vs 59.5 kg; p=5.2e-07), LMI (22.0 vs 19.3 kg/m2; p=6.3e-12), ALMI 
(9.8 vs 8.5 kg/m2; p=1.8e-10) and SMI (0.32 vs 0.28; p=1.8e-11) (Table 3.3 
B). 
Among the six clusters identified in males the MO group (BMI= 35.5 
kg/m2) have the highest values for fat mass comparing to other five 
clusters (FM= 42.4 kg; FMI= 13.9 kg/m2; FM/LM=0.6) but also the highest 
values for some lean and bone mass markers (LM=67.3 kg; and BMC= 
3667.6 g) (Table 3.3 B). 
SMI and BMD do not discriminate very much among the clusters both in 






Metabolic profile across the BC clusters 
Several metabolic parameters were identified and compared among 
female and males' clusters to better understand their characteristics 
(Table 3.5). 
In females, significant differences emerged among the five clusters. In 
particular, the highest levels of HDL cholesterol, and the lowest ones of 
triglycerides, glycated haemoglobin, glucose, insulin, HOMA (IR and ), 
urea and diastolic pressure were reported in NW cluster. 
The female cluster with the highest BMI (LOB) shows the lowest level of 
calorie intake in comparison of LOA that has the highest one, in addition, 
LOB cluster have the highest values of triglycerides, glycated 
haemoglobin, glucose, insulin, HOMA (IR and ), urea and diastolic 
pressure. Instead, no significant differences among clusters emerged for 
adherence to the NU-AGE diet and the circulating levels of total 
cholesterol and LDL, albumin, creatinine, 25(OH)D, PTH and systolic blood 
pressure among the five clusters (Table 3.4 A). 
In addition to the metabolic parameters, other variables that may impact 
the metabolic profile were analyzed, such as the number of subjects using 
drugs for the control of cholesterol, glucose, blood pressure and 
supplementation of calcium and vitamin. Significant differences emerged 
in in the percentage of females taking hypertensive drugs (62.2% in LOB), 
this may explain the similar values in systolic blood pressure across the 
five clusters. Moreover, differences emerged in clusters with similar BMI, 
LOA and LOB with 34.4% and 62.2% of subjects taking anti-hypertensive 
drugs, respectively. Despite the similar BMI, the percentage of females 
taking anti-hypertensive drugs is higher in the cluster with higher fat 
markers. The LOA cluster shows the lowest percentage of female taking 




supplementation (3.3%) while the highest values were reported in OWB 
cluster (25.5%) and LOB cluster (18.3%), respectively (Table 3.4 A). 
Handgrip strength and PASE score were used to evaluate differences in 
the physical functioning. LOA cluster shows the highest values for the 
handgrip strength test (Table 3.4 A). This cluster is indeed characterized 
by the highest values for lean mass markers (FMI, LMI, ALMI) (Table 3.3 
A). The PASE score is highest in the NW and lowest one in the LOB cluster 
(Table 3.4 A).  
While in female clusters no significant difference emerged for adherence 
to the NU-AGE diet, the NW male cluster shows the highest adherence in 
comparison to others. In addition, the NW cluster have the highest levels 
of HDL cholesterol and the lowest ones of triglycerides, glucose, insulin, 
HOMA IR and urea. As the LOB female cluster, males within the cluster 
with the highest BMI (MO) showed the lowest levels of calorie intake. 
Moreover, MO cluster have the lowest levels of HDL cholesterol and the 
highest ones of triglycerides, glucose, insulin, HOMA IR, HOMA  and 
urea. Males in the OWA cluster have the lowest levels of HOMA . The 
highest and the lowest levels of albumin are found within the LOA and 
LOB clusters respectively, while the highest and the lowest levels of PTH 
are found within the OWB and OWA clusters, respectively.  
Instead, no significant differences among clusters emerged for the 
circulating levels of total cholesterol and LDL, glycate haemoglobin, 
creatinine, 25(OH)D, diastolic and systolic blood pressure (Table 3.4 B). 
Like for female clusters, also among the six clusters no significant 
differences emerged in the percentage of elderly taking statins and drugs 
for the reduction of glycemia, while all the males within the MO cluster 
were using anti-hypertensive drugs. This could explain the similar values 
in systolic and diastolic blood pressure across the six clusters. In addition, 




hypertensive drugs: LOA cluster have 46.7% instead of LOB cluster with 
63.7%, while OWA and OWB shows 35.0% and 51.9% respectively. Also in 
this case, the percentage of mlaes taking anti-hypertensive drugs is higher 
in the cluster with higher fat markers. None of the males in MO cluster 
was taking vitamin D supplementation but no significant difference 
emerged among clusters. Moreover, no males within the LOB and MO 
clusters was taking calcium supplementation, while the higher 
percentage (15%) of subjects used calcium supplementation was in OWA 
cluster (Table 3.4 B). Despite no differences emerged among the six 
clusters for the levels of vitamin D (supplementation and also serum 
25(OH)D level), it is interesting to note that OWA, LOB and MO have the 
highest values for bone mass markers (T-score and BMC) (Table 3.3 B). 
Males within the LOA cluster have the highest values for the handgrip 
strength test (Table 3.4 A). Indeed, this cluster is characterized by the 
highest values for some lean mass markers (LMI and ALMI) (Table 3.3 B). 
While the PASE score is highest in the OWA and lowest in the LOB cluster 
(Table 3.4 B). 
Figure 3.2 shows the comparison of each metabolic parameter between 
clusters. When comparing cluster with similar BMI (OWA vs OWB, LOA vs 
LOB) no significant difference emerged for all the metabolic parameters, 
with the exception of values for triglyceride (Figure 3.2 A, panel B) that 
resulted higher in female LOB with respect to LOA; and values for albumin 
(Figure 3.2 B, panel H), that resulted higher in male LOA with respect to 
LOB. As expected, all the metabolic parameters analyzed are within 
normal range (see footnotes in Table 3.4), since in the NU-AGE study all 
participants were healthy elderly, except triglycerides and urea levels 
within the MO cluster and glucose and systolic blood pressure in the LOA, 






Distribution of the BC clusters per Country  
Figure 3.3 shows the percentage of subjects of each country within each 
BC cluster for female and males. 
The NW and OWA female clusters are mainly composed of Dutch (32% 
and 28% respectively) and English subjects (29% and 24% respectively). 
While the highest percentage of Italians (38%) is in OWB cluster followed 
by the English subjects (26%); in the LOA cluster the majority of subjects 
comes from UK (39%) and France (30%) while the LOB cluster is 
represented for the 51% by Polish subjects followed by a 20% of Dutch 
subjects (Figure 3.3 A). 
The NW male cluster is mainly composed by English (33%) and French 
(30%) subjects while the OWA cluster is represented by Dutch (44%) 
Polish (21%) and French (21%) subjects, within the OWB cluster the 
majority of subjects are Italians (37%) and Polish (24%), the majority of 
English (42%) and French (46%) subjects belong to the LOA cluster, the 
LOB cluster is mainly composed by Italians (31%), Dutch (25%) and Polish 
(25%), the MO cluster is mainly composed by Dutch (33%) and Polish 







The aim of this study is to define a BC profile in the elderly across Europe. 
The 1121 elderly participants to the European project NU-AGE have been 
thoroughly studied for their dietary intake (Berendsen et al., 2014) and 
their anthropometric, metabolic, physical and cognitive status (Santoro 
et al., 2014), in particular DXA scan was assessed to evaluate their BC in 
terms of fat, lean and bone mass.  
Due to significant aging-related depletion of sex hormones such as rapid 
loss of estradiol and progesterone in women after menopause, it has 
been thought that in elderly BC of women would become more similar to 
men. On the contrary, many results (Lauretta et al., 2017), including ours, 
demonstrate that there is a great difference among BC in elderly women 
and men. In fact, female aged 65 or more years old tend to have higher 
fat mass, in particular in the gynoid region, but lower lean and bone mass 
than males aged same. As anticipated, what makes women different from 
men is represented by sex hormones, i.e. estrogen, progesterone and 
testosterone, and given the increase in older people, there is a great 
interest in understanding the complex interrelationships between 
increasing age and hormonal regulation. 
Age-associated endocrine changes comprise the decline of basal 
hormonal levels, pulsatile hormone distribution, and activity of hormonal 
axis, which result in changes in body composition. Men and women 
experience different age-associated alterations of the hormonal system: 
significant decrease in testosterone and loss of estradiol and 
progesterone, respectively. As mentioned in introduction, there is a 
strong association between Aging and several diseases like osteoporosis, 
diabetes mellitus type 2, frailty, and sarcopenia (Lauretta et al., 2017) and 
gender-specific differences with respect to symptoms, interactions, 




As mentioned, sarcopenia is closely related to age, and is defined by loss 
of muscle mass and strength, and associated with chronic disease, 
sarcopenic obesity, and prolonged immobilization (Rosenberg, 1997). In 
addition, a reduction in anabolic hormones plays a key role in the 
development and maintenance of sarcopenia. In particular, it has been 
shown that testosterone reduction in older men plays a key role, 
consequently it is useful to administer testosterone in hypogonadal men 
in order to reduce muscle strength loss (Lauretta et al., 2017). In contrast, 
there is no evidence of an association between decreased estrogen and 
loss of muscle mass in women. Another gender difference can be found 
in the pathophysiology of osteoporosis. In fact, women tend to have a 
very rapid reduction in bone content at a younger age than men, who 
have higher bone density and content and develop principles of 
osteoporosis at a later age. In addition, women have a more pronounced 
decrease in hormone production than men, as estrogen plays an 
important role in bone health this aspect may be linked to the presence 
of fractures 5-10 years earlier in women than men (Elmer and al., 2017). 
Our results showed also geographic differences in BC across the 5 
countries of NU-AGE project. Overall, French participants have the 
highest values of lean mass markers and the lower of fat mass compared 
with participants from the other countries (Italy, the Netherlands, Poland, 
and the United Kingdom). In contrast, Polish participants have the higher 
values of fat mass markers while the highest value of bone mass markers 
are reported for Dutch elderly. These differences among the 5 countries 
could be attributed to genetic predisposition, dietary habits, lifestyle or 
physical activity, stress or education, because the criteria for exclusion 
and inclusion in the study were the same for all countries (Santoro et al., 
2014). The French elderly are found to be the most adherent to the NU-
AGE diet, although they have a higher caloric intake than other countries. 




low-fat meat than others (Berendsen et al., 2018), which may contribute 
to higher values of lean mass than other countries. Despite the higher 
presence of lean mass value, the French subjects do not show the highest 
values for physical activity, PASE score and handgrip strength. In contrast, 
Polish, who have the highest levels of fat mass, have higher intakes of 
whole grains, eggs, vegetable and low-fat cheese (Berendsen et al., 2018), 
also show the lowest values for handgrip strength. Obesity rates in the 
European adult population (18-75 years old) varies by country; Romania, 
Italy Netherlands, Belgium, and Sweden have the lowest rates of obesity 
(9.4%, 10.7%, 13.3%, and 14%, respectively) while the highest rates are in 
Malta (26%), Latvia (21.3%), Hungary (21.2%), Estonia (20.4%), and the 
United Kingdom (20.1%) (Eurostat, 2016). In addition, an increase in 
obesity rates has been shown in European countries between 2010 and 
2014, with the exception of Italy (Blundell et al., 2017) and it is affected 
by aging. In fact, a 2016 Eurostat study shows that the obesity rate in 
those aged 65-74 is 22.5% for France, 15.7% for Italy, 17.7% for the 
Netherlands, 28.4% for Poland, and 20.7% for the United Kingdom. These 
data are partially confirmed by our results, in fact Polish subjects are 
found to have more fat mass than other countries considered in the 
study, as opposed to French subjects who have more lean mass. This 
could be explained by the type of measurement, self-reported BMI in the 
Eurostat study and standardized and accurate measures such as DXA in 
the NU-AGE project. Though BMI has always been considered a valid tool 
to assess overall adiposity, it fails to distinguish between the relative 
contribution of fat mass and lean mass (Blundell et al., 2014). Moreover, 
different metabolic parameters were compared across BC clusters 
identified in elderly males and females. It is well known that an increase 
in fat mass, together with aging, can cause medical complications, such 
as hypertension, diabetes and cardiovascular disease. The inclusion and 




subjects, as a result all metabolic parameters are within the range, 
although, as shown in the results, there are differences between clusters. 
In particular, subjects within the cluster with lowest BMI have the highest 
HDL cholesterol levels but the lowest triglycerides, glucose, insulin, 
HOMA, urea compared with the other clusters and females have the 
lowest level of diastolic pressure. While the clusters with higher BMI have 
the lowest HDL cholesterol levels but the highest triglycerides, glucose, 
insulin, HOMA (IR and ) and urea and diastolic pressure (only females) 
levels compared with the other clusters.  The similar levels of cholesterol 
and LDL among the clusters may be explained by the fact that the number 
of subjects taking statins does not change among clusters. In addition, 
considering groups with similar BMI the percentage of subjects taking 
antihypertensive drugs is higher in the group with higher fat mass 
markers. The percentage of elderly taking vitamin D and calcium 
supplements is higher in the clusters with higher BMI who also have 
higher BMC and T-score values. Additionally, subjects with highest values 
of lean mass markers have also highest values of handgrip strength. 
In conclusion, the results presented in this paper provide a synthesis of 
the health status of elderly subjects in Europe that can be used as a 
reference for studies related to gender differences in body composition, 
disease conditions, and differences between European countries. The 
study has some weaknesses, such as the fact that the subjects are healthy 
volunteers, highly educated and interested in nutrition and health issues 
and therefore may not be representative of the population of the same 
age. Although the weaknesses, there are also strengths. Indeed, the fact 
of using standardized and accurate tools to study body composition, i.e. 








n = 620 
Men 
n = 501 
p-value q-value 
Age (years) 70.7 ± 3.9 71.0 ± 4.1 NS NS 
Weight (kg) 67.7 ± 11.2 80.6 ± 12.6 <2.2e-16 <2.2e-16 
Height (cm) 160.0 ± 6.7 173.0 ± 6.4 <2.2e-16 <2.2e-16 
BMI (kg/m2) 26.5 ± 4.1 26.9 ± 3.7 1.16e-02 2.73e-02 
Waist circumference (cm) 86.9 ± 10.8 96.7 ± 11.1 <2.2e-16 <2.2e-16 
Hip circumference (cm) 103.3 ± 9.1 101.5 ± 7.6 1.32e-03 3.54e-03 
Waist to Hip circumference ratio 0.85 ± 0.31 0.95 ± 0.06 <2.2e-16 <2.2e-16 
Education     
Primary school, N (%) 25 (4.0) 12 (2.4) 
NS NS 
Low Secondary school, N (%) 71 (11.5) 72 (14.4) 
Up Secondary school, N (%) 238 (38.4) 195(38.9) 
College, N (%) 286 (46.1) 222 (44.3) 
Education (years) 12.4 ± 3.4 13.0 ± 3.8 2.15e-02 NS 
Diet Assessment     
Adherence to NU-AGE diet 52.5 ± 10.3 50.0 ± 9.3 6.80e-05 2.16e-04 
Calorie Intake (kcal) 
1680.9 
±327.8 
2123.3 ± 445.0 <2.2e-16 <2.2e-16 
Physical Functioning     
Hand grip strength (kg) 25.2 ± 5.5 39.6 ± 7.0 <2.2e-16 <2.2e-16 
PASE Score 127.8 ± 48.9 140.9 ± 59.5 3.53e-04 1.01e-03 








n = 620 
Men 
n = 501 
p-value q-value 
FM (kg) 26.2 ± 8.06 22.0 ± 8.37 <2.2e-16 <2.2e-16 
FMI (kg/m2) 10.3 ± 3.16 7.35 ± 2.74 <2.2e-16 <2.2e-16 
FM/LM 0.65 ± 0.19 0.39 ± 0.14 <2.2e-16 <2.2e-16 
LM (kg) 40.3 ± 4.97 57.1 ± 6.71 <2.2e-16 <2.2e-16 
LMI (kg/m2) 15.7 ± 1.53 19.1 ± 1.80 <2.2e-16 <2.2e-16 
ALMI (kg/m2) 6.56 ± 0.77 8.47 ± 0.87 <2.2e-16 <2.2e-16 
SMI 0.25 ± 0.03 0.32 ± 0.04 <2.2e-16 <2.2e-16 
T-score -0.82 ± 1.2 -0.19 ± 1.2 <2.2e-16 <2.2e-16 
BMC (g) 2092.5 ± 357 2947.8 ± 483 <2.2e-16 <2.2e-16 
BMD (g/cm2) 1.03 ± 0.11 1.19 ± 0.11 <2.2e-16 <2.2e-16 
Android/Gynoid FM* 0.50 ± 0.15 0.78 ± 0.21 <2.2e-16 <2.2e-16 
Android FM/LM* 0.79 ± 0.30 0.61 ± 0.25 2.70e-16 2.82e-15 
l1 l4 BMD (g/cm2) ∆ 1.0 ± 0.17 1.17 ± 0.2 <2.2e-16 <2.2e-16 
l1 l4 T-score ∆ -1.0 ± 1.4 -0.11 ± 1.65 2.74e-05 9.53e-05 
Neck BMD (g/cm2) ∆ 0.78 ± 0.12 0.88 ± 0.14 <2.2e-16 <2.2e-16 
Neck T-score∆ -1.36 ± 0.93 -1.07 ± 0.9 <2.2e-16 <2.2e-16 
BMI, body mass index; FM, fat mass; FMI, fat mass index; LM, lean mass; LMI, non-bone lean 
mass index; ALMI, non-bone appendicular lean mass index; SMI, skeletal mass index; BMC, 
bone mineral content; BMD, bone mineral density; Values are means ± SDs, unless otherwise 
stated. NS, not statistically significant. * (F=474, M=416); ∆ (F=387, M=298); p-value (Mann - 










n = 236 
Poland 
n = 222 
UK 
n = 246 
France 
n = 184 
The 
Netherlands 
n = 233 
p-value q-value 
Age (years) 71.7 ± 3.8 71.3 ± 3.8 70.1 ± 3.9 70.1 ± 3.8 71.0 ± 4.1 1.31e-06 5.33e-06 
Female sex 119 (50.4) 127 (57.2) 154(62.6) 91 (49.5) 129(55.1) 3.35e-02 NS 
Weight (kg) 72.7 ± 12.7 75.7 ± 14.5 73.5 ± 13.5 70.0 ± 12.7 74.7 ± 13.4 1.65e-03 4.34e-03 
Height (cm) 163.9 ± 9.4 163.9 ± 9.3 166.0 ± 9.0 166.0 ± 9.0 169.2 ± 8.2 8.59e-10 2.86e-09 
BMI (kg/m2) 27.0 ± 3.8 28.0 ± 4.1 26.6 ± 3.9 25.4 ± 3.4 26.0 ± 3.6 1.45e-11 1.05e-10 
Waist circumference 
(cm) 
92.8 ± 11.4 93.3 ± 11.8 91.4 ± 12.0 86.3 ± 11.4 91.6 ± 11.9 1.98e-08 1.03e-07 
Hip circumference 
(cm) 
101.4 ± 7.4 103.6 ± 8.7 104.7 ± 9.1 99.1 ± 8.5 103.2 ± 7.9 2.45e-12 1.10e-11 
Waist to Hip 
circumference ratio 
0.9 ± 0.1 0.9 ± 0.1 0.9 ± 0.1 0.9 ± 0.1 0.9 ± 0.1 4.75e-09  
Education        
Primary school N, (%) 25 (10.6) 0 (0.0) 1 (0.4) 4 (2.2) 7 (3.0) 
<2.2e-16 <2.2e-16 
Low Secondary 
school N, (%) 
61 (25.9) 8 (3.6) 0 (0.0) 46 (25.0) 28 (12.0) 
Up Secondary school 
N, (%) 
94 (39.8) 41 (18.5) 88 (35.8) 60 (32.6) 149 (64.0) 
College N, (%) 56 (23.7) 172 (77.5) 157 (63.8) 74 (40.2) 49 (21.0) 
Education (years) 11.2 ± 4.2 15.4 ± 2.7 11.8 ± 1.7 12.5 ± 3.7 12.3 ± 3.7 <2.2e-16 <2.2e-16 
Diet Assessment        
Adherence to NU-
AGE diet 
52.8 ± 9.5 52.7 ± 10.1 50.5 ± 8.8 55.9 ± 9.1 46.3 ± 9.8 <2.2e-16 <2.2e-16 
Calorie Intake (kcal) 1733 ± 376 1850 ± 518 1903 ± 389 2024 ± 482 1912 ± 405 1.60e-09 9.62e-09 





31.1 ± 9.7 
23.5 ± 5.3 
38.9 ± 6.6 
30.4 ± 9.9 
23.7 ± 4.6 
39.3 ± 7.7 
34.8 ± 9.1 
29.7 ± 5.4 
43.4 ± 7.3 
31.1 ± 8.8 
23.9 ± 4.1 
38.2 ± 5.8 
30.5 ± 9.3 
23.8 ± 4.8 










131.7 ± 63.6 
151.2 ± 
53.0 







BMI, body mass index; FM, fat mass;FMI, fat mass index; LM, lean mass;LMI, non-bone lean 
mass index;  ALMI, non-bone appendicular lean mass index; SMI, skeletal mass index; BMC, 
bone mineral content; BMD, bone mineral density; Values are means ± SDs, unless otherwise 
stated. NS, not statistically significant. * (N=875); ∆ (N=704); p-value (Mann - Whitney and 





n = 236 
Poland 
n = 222 
UK 
n = 246 
France 
n = 184 
The 
Netherlands 
n = 233 
p-value q-value 
FM (kg) 26.2 ± 7.4 28.0 ± 9.1 23.3 ± 7.9 20.4 ± 7.4 23.2 ± 8.5 <2.2e-16 <2.2e-16 
FMI (kg/m2) 9.9 ± 3.0 10.5 ± 3.5 8.5 ± 3.1 7.5 ± 2.9 8.2 ± 3.1 <2.2e-16 <2.2e-16 
FM/LM 0.60 ± 0.19 0.64 ± 0.24 0.50 ± 0.18 0.42 ± 0.17 0.49 ± 0.20 <2.2e-16 <2.2e-16 
LM (kg) 45.0 ± 8.7 45.6 ± 10.3 48.8 ± 10.4 50.8 ± 10.6 49.2 ± 9.9 7.45e-11 4.96e-10 
LMI (kg/m2) 16.6 ± 2.0 16.7 ± 2.3 17.6 ± 2.5 18.3 ± 2.3 17.0 ± 2.2 1.68e-12 1.39e-11 
ALMI (kg/m2) 7.4 ± 1.2 7.1 ± 1.1 7.5 ± 1.3 7.9 ± 1.3 7.2 ± 1.2 3.79e-09 2.13e-08 




-0.19 ± 1.25 
-0.92 ± 
1.23 
-0.58 ± 1.23 -0.29 ± 1.21 3.90e-12 3.17e-11 
BMC (g) 2463 ± 597 2610 ± 615 2233 ± 494 2327 ± 489 2729 ± 621 <2.2e-16 <2.2e-16 
BMD (g/cm2) 1.07 ± 0.15 1.15 ± 0.12 1.06 ± 0.13 1.11 ± 0.12 1.14 ± 0.12 <2.2e-16 <2.2e-16 
Android/Gynoid FM* 0.65 ± 0.22 0.63 ± 0.21 - 0.54 ± 0.20 0.67 ± 0.24 9.06e-08 4.25e-07 
Android FM/LM* 0.77 ± 0.28 0.85 ± 0.28 - 0.45 ± 0.18 0.70 ± 0.25 <2.2e-16 <2.2e-16 
l1 l4 T-score∆ -0.84 ± 
1.38 
-0.36 ± 1.78 -0.63 ± 
1.53 
- - 4.14e-02 NS 
l1 l4 BMD (g/cm2)∆ 1.10 ± 0.17 1.15 ± 0.22 0.97 ± 0.18 - - <2.2e-16 <2.2e-16 
Neck T-score∆ -1.39 ± 
0.95 
-1.19± 0.92 -1.12 ± 
0.96 
- - 2.92e-02 NS 




Table 3.4 A | Five body composition groups identified by a cluster analysis performed on ten 
BC parameters and BMI in women (N=620) 
 
Table 3.4 B| Six body composition groups identified by a cluster analysis performed on ten BC 


































































































Low Obesity A 
























Low Obesity B 


















































Values are expressed as mean values ± SD, unless otherwise indicated. 
1, Significant difference between OWA and OWB (1: p<0.0001) 





































































































Low Obesity A 
























Low Obesity B 


































(n = 89) 
Overweight 
A 
(n = 251) 
Overweight 
B 
(n = 137) 
Low Obesity 
A 
(n = 61) 
Low Obesity B 
(n = 82) 
p-value 
Adherence to NU-AGE 
diet 
54.9 ± 11.0 52.1 ± 10.3 51.6 ± 9.0 54.1 ± 9.6 51.7 ± 11.7 NS 














220.5 ± 39.8 222.5 ± 37.2 217.3 ± 40.6 214.3 ± 39.9 NS 
HDL (mg/dL) 76.3 ± 19.8 66.9 ± 39.8 66.1 ± 16.5 60.1 ± 14.8 59.6 ± 16.9 4.72e-09 
LDL (mg/dL) 136.8 ± 
39.6 
132.7 ± 36.4 136.2 ± 33.7 137.3 ± 38.9 129.9 ± 35.0 NS 
Triglycerides (mg/dL) 89.1 ± 31.9 104.4 ± 45.7 100.9 ± 36.3 99.5 ± 33.1 123.7 ± 55.0 3.02e-05 
Glycated Haemoglobin 
(%) 
5.7 ± 0.3 5.7 ± 0.3 5.7 ± 0.4 5.8 ± 0.4 5.9 ± 0.4 7.117e-03 
Glucose (mmol/L) 5.2 ± 0.7 5.4 ± 0.6 5.5 ± 0.7 5.8 ± 1.1 5.9 ± 0.9 7.27e-09 
Insulin (mcU/mL) 6.1 ± 3.4 8.4 ± 5.7 7.8 ± 3.8 11.3 ± 6.4 12.3 ± 6.3 2.95e-16 
HOMA IR 1.5 ± 0.9 2.1 ± 1.6 1.9 ± 1.0 3.0 ± 2.0 3.3 ± 1.8 < 2.2e-16 
HOMA β (%) 74.3 ± 37.1 90.9 ± 56.5 84.3 ± 46.6 100.3 ± 49.8 109.1 ± 61.2 6.58e-05 
Urinary Urea (g/24h) 16.9 ± 4.5 17.9 ± 5.1 16.8 ± 4.7 20.0 ± 4.9 20.1 ± 5.2 9.56e-08 
Albumin (g/L) 45.7 ± 4.4 45.5 ± 4.2 44.7 ± 3.6 45.9 ± 4.1 44.9 ± 3.2 NS 
Creatinine (mmol/L) 68.6 ± 11.9 69.8 ± 12.5 67.8 ± 11.7 71.4 ± 12.5 70.5 ± 10.3 NS 
25(OH)D (ng/mL) 26.8 ± 10.2 25.7 ± 8.9 24.9 ± 10.6 23.8 ± 9.4 23.3 ± 7.5 NS 
PTH (pg/mL) 46.7 ± 32.1 40.3 ± 24.0 47.4 ± 28.9 41.9 ± 22.2 43.9 ± 22.8 NS 
Diastolic pressure 
(mmHg) 





136.3± 19.9 138.3 ±21.8 138.9±20.5 139.9± 20.6 NS 
Use of medicines/ 
supplements 
      
Statins (n=155; %) 18.0 25.9 20.4 29.5 34.1 NS 
Diabetics (n=16; %) 1.1 2.4 0.7 4.9 6.1 NS 
Hypertension (n=265; 
%) 
23.6 43.4 46.0 34.4 62.2 8.035e-06 
Vitamin D (n=139; %) 22.5 23.5 25.5 13.11 20.7 < 2.2e-16 
 
Calcium (n= 78; %) 11.2 12.7 13.9 3.3 18.3 < 2.2e-16 
Physical Functioning       
Handgrip strength (kg) 25.0 ± 5.7 25.4 ± 5.4 24.1 ± 5.9 26.7 ± 6.1 25.4 ± 4.7 2.529e-02 
PASE score 141.2 ± 
43.7 




Table 3.5 B | Metabolic profile across the five body composition clusters in men. 
Population based reference ranges for: Total Cholesterol: <200mg/dL ; HDL: > 60mg/dL; LDL: 
<100 mg/dL; Triglycerides: <150 mg/d; Glycated Haemoglobin: < 7.5%;Glucose (serum): 4.1-5.9 
mmol/L; Insulin: 2-25 mcU/ml; HOMA IR: 0.23-2.5; HOMA β (%): 0-100; Urinary Urea:10-30 
g/24h; Albumin (serum): 32-49 g/L; Creatinine (serum): 50-120 mmol/L; 25(OH)D (serum): 30-
100 (ng/mL); PTH (serum): 10-70 pg/mL; Diastolic pressure: <90 mmHg; Systolic pressure: < 140 







(n = 122) 
Overweight 
A 
(n = 20) 
Overweight 
B 
(n = 233) 
Low 
Obesity A 
(n = 34) 
Low 
Obesity B 
(n = 80) 
Moderate 
Obesity 




51.7 ± 9.2 50.9 ± 12.1 50.3 ± 9.1 49.2 ± 8.0 47.2 ± 9.7 49.5 ± 5.9 2.39e-02 














Cholesterol (mg/dL) 194.4 ± 
33.6 







HDL (mg/dL) 57.9 ± 16.1 53.3 ± 14.4 50.9 ± 13.7 50.1 ± 13.9 44.8 ± 12.1 40.6 ± 10.2 4.32e-09 
LDL (mg/dL) 119.2 ± 
30.3 


















5.7 ± 0.4 5.7 ± 0.2 5.8 ± 0.5 5.8 ± 0.7 5.8 ± 0.7 5.9 ± 0.3 NS 
Glucose (mmol/L) 5.6 ± 0.8 5.8 ± 0.9 5.9 ± 0.9 6.0 ± 1.1 6.1 ± 1.0 6.3 ± 0.7 3.78e-05 
Insulin (mcU/mL) 6.3 ± 3.7 6.9 ± 2.7 9.6 ± 6.4 14.1 ± 14.1 14.1 ± 8.8 22.2 ± 10.7 < 2.2e-16 
HOMA IR 1.6 ± 1.1 1.8 ± 0.8 2.6 ± 2.0 3.9 ± 4.0 3.9 ± 2.6 6.4 ± 3.5 < 2.2e-16 









22.6 ± 6.0 24.0 ± 4.0 22.7 ± 6.1 25.5 ± 6.8 24.6 ± 7.6 31.6 ± 12.6 1.47e-03 
Albumin (g/L) 45.9 ± 4.8 47.2 ± 4.8 45.4 ±3.6 47.6 ± 4.5 44.3 ± 3.4 44.7 ± 3.5 4.83e-03 
Creatinine (mmol/L) 88.6 ± 4.8 88.5 ± 17.2 90.3 ± 17.3 92.4 ± 17.2 89.2 ± 11.6 92.9 ± 27.4 NS 
25(OH)D (ng/mL) 25.6 ± 8.7 24.7 ± 7.0 24.3 ± 8.5 23.4 ± 8.7 22.4 ± 8.4 25.2 ± 7.1 NS 
PTH (pg/mL) 38.7 ± 27.1 40.0 ± 28.4 46.3 ± 22.5 37.1 ± 19.1 45.9 ± 22.0 46.1 ± 20.7 1.98e-03 
Diastolic 77.4 ± 10.4 76.6 ± 8.2 76.2 ± 10.4 81.3± 7.6 77.7± 10.2 77.6± 8.1 NS 
Systolic 134.9 ± 
17.8 





Use of medicines/ 
supplements 
       
Statins (n=130; %) 20.5 15.0 28.3 32.3 30.0 25.0 NS 
Diabetics (n=26; %) 3.2 0 10.7 2.9 11.3 8.3 NS 
Hypertension 
(n=242; %) 
30.3 35.0 51.9 46.7 63.7 100.0 4.223e-08 
Vitamin D (n=26; %) 4.1 5.0 5.6 5.9 6.3 0.0 NS 
Calcium (n=15; %) 1.6 15.0 3.9 2.9 0.0 0.0 2.869e-02 
Physical Functioning        
Handgrip strength 
(kg) 
39.6 ± 6.3  41.8 ± 7.5 38.2 ± 6.8 41.9±7.9 41.3 ± 7.1 44.4 ± 9.1 5.653e-04 
PASE score 153.8 ± 
58.1 










Figure 3.2 A | Box-plots and significant differences of metabolic parameters among clusters in 
women. Statistical analysis was perfomed by Kruskal - Wallis test (p-values: *p<0.05, 








Figure 3.2 B | Box-plots and significant differences of metabolic parameters among clusters in 





















4. ASSOCIATION OF BODY COMPOSITION WITH INFLAMMATORY AND 
METABOLIC MARKERS IN ELDERLY 
 
This Chapter regard data that have already been reported in publication 
Gender-specific association of body composition with inflammatory and 
adipose-related markers in healthy elderly Europeans from the NU-AGE 
study (Santoro et al., 2018b). 
 
4.1 INTRODUCTION 
Due to its association with several diseases and decline in health status, 
the assessment of body composition (BC) is essential additionally, it is 
fundamental to characterize the metabolic status (Lemos et al., 2017). As 
mentioned in the general introduction, there is an association between 
changes in BC and aging. Those changes are mainly related to three 
distinct processes: i) a progressive decrease in lean mass (LM) and an 
increase in fat mass (FM) known as sarcopenia and sarcopenic obesity 
(Müller et al., 2014); ii) a redistribution of FM, central and visceral (Fox et 
al., 2007); iii) a reduction in height and bone mineral density (BMD) 
(Bazzocchi et al., 2013; Jafarinasabian et al., 2017). Moreover, the 
incidence of the major causes of deaths in U.S. and European population 
(Pischon et al.,2008; Freisling et al., 2017), i.e. type 2 diabetes, 
cardiovascular disease (CVD) and insulin resistance, is related to an 
excessive body fat accumulation.  
A chronic inflammation driven by nutrient excess/overnutrition, called 
metaflammation, characterize the main metabolic diseases (Hotamisligil 
GS, 2017). It has been hypothesized that this inflammatory status may 
precede/contribute to inflammaging, i.e. the chronic, low-grade, 




2000; Franceschi et al., 2016) and that metabolic age-related 
dysfunctions and diseases can be considered manifestations of age 
acceleration (Franceschi C, 2017). Both conditions are characterized by 
an increased production of the pro-inflammatory cytokines, i.e. 
interleukin 6 (IL-6) or interleukin 8 (IL-8) (Prattichizzo et al., 2018). 
Interestingly inflammageing does not simply reflect an increase of pro-
inflammatory markers but an overall activation of inflammatory systems 
that probably also promotes a concomitant rise in the levels of anti-
inflammatory mediators (Franceschi et al., 2007; Morrisette-Thomas et 
al., 2014); Morisette et al., 2014).  
Due to an increase of adipose tissue and a decrease of bone and muscle 
tissue during aging, there is rise in proinflammatory adipokines, 
chemokines and citokines and a reduction in anti-inflammatory ones 
which contributes to local and systemic inflammation and disturbances in 
glucose homeostasis (Mancuso P, 2016). 
A systemic study on the age-related changes in BC was missing and, to 
the best of our knowledge, no study to date has evaluated the 
relationship between composition and regional distribution of fat, lean 
and bone masses and the relative inflammatory profile in healthy elderly 
subjects. Due to its relatively low cost, fast acquisition time and low 
radiation exposure, as compared to other available techniques, DXA is 
considered the gold standard for the assessment of human BC (Alberto 
Bazzocchi et al., 2013; Guglielmi et al., 2016). As mentioned, DXA can 
assess three body-composition components at a molecular level: BMC, 
LM, and FM in addition of BMD. Moreover, DXA allows to measure total-
body and standard regional body composition, arms, legs, android and 
gynoid regions. Due to all of these advantages, DXA is the ideal method 
for clinical use and longitudinal studies, in both adults and children. The 
aim of the current study was to evaluate correlations between regional 




adipose parameters. To fulfill this objective, the BC of 1121 gender-
balanced-free-living subjects from the European NU-AGE project, “New 
dietary strategies addressing the specific needs of elderly population for 







Study design and participants 
NU-AGE (http://www.nu-age.eu/) is a one-year, multicenter, 
randomized, single-blind, controlled trial (registered with 
clinicaltrials.gov, NCT01754012) with two parallel groups (i.e., dietary 
intervention and control). The recruitment was carried out during April 
2012 and January 2014 in five European centers located in France 
(Clermont-Ferrand), Italy (Bologna), the Netherlands (Wageningen), 
Poland (Warsaw), and the United Kingdom (UK, Norwich). The 
recruitment of participants has been described in detail previously 
(Berendsen et al., 2014; Santoro et al., 2014). Originally, 2668 man and 
women volunteers from the community aged 65–79 years, free of major 
overt chronic diseases compromising 2-year survival (i.e., cancer, 
dementia), free and independent living, and competent to make own 
decisions, were recruited in the baseline assessment. After testing the 
exclusion criteria, i.e. included severe heart diseases, type 1 and insulin-
treated type 2 diabetes, chronic use of corticosteroids, recent use of 
antibiotics or vaccinations, change in habitual medication use, presence 
of frailty (Fried et al., 2001), malnutrition (body mass index <18.5 kg/m2 
or 10% weight loss within 6 months), or food allergy/intolerance requiring 
special diets, 1296 were eligible to participate in the NU-AGE trial. 
Complete DXA scan was performed in 1121 participants, at baseline, and 
were included from the NU-AGE study cohort (France (N= 184; 16.4%), 
Italy (N=236; 21%), the Netherlands (N= 233; 20.7%), Poland (N=222; 
19.8%), and UK (N=246; 21.9%)).  
 
Assessment of Body Composition 
A whole-body DXA scan has been carried out to measure total and 




five recruiting centre: Lunar iDXA, GE Healthcare, Madison, WI, USA – 
enCORETM 2011 software version 13.6 (Bologna, Italy); Discovery QDR, 
Hologic Inc., Bedford, MA, USA – software version 3 (Clermont-Ferrand, 
France); Lunar Prodigy, GE Healthcare, Madison, WI, USA – enCORETM 
2011 software version 13.6 (Wageningen, the Netherlands and Warsaw, 
Poland); and Discovery Wi, Hologic Inc., Bedford, MA, USA (Norwich, UK). 
The scanners were calibrated daily using a standard calibration block 
supplied by the manufacturers following standard Quality Control 
procedures. DXA scans were performed by trained technicians according 
to state-of-the-art technique and manufacturers recommendation.  
No metal items were present during densitometry. Participants were 
positioned in the center of the scanning field in a supine position with the 
arms at sides and separated from the trunk. As mentioned, 
measurements of total-body and standard regional body composition, 
such as trunk, upper limbs, android and gynoid region were defined by 
DXA. Android and gynoid regions were not defined by the densitometer 
used in UK. For each region, DXA scanned the weight (in g) of total mass, 
FM, non-bone LM, and BMC. The weight (in g) of total mass, whole body 
fat mass (FM), non-bone whole body lean mass (LM), and bone mineral 
content (BMC). In order to reduce the possible error generated by the use 
of different DXA machines, specific indices have been used as reported in 
Table 3.1 of third chapter. The indexes of total body FM/LM, FMI, and 
LMI are considered markers of general mass, android/gynoid FM is 
related of central/peripheral distribution of FM, while the FM/LM 
android, and ALMI and SMI indices are markers of central abdominal 
distribution, low muscle mass respectively. Moreover, bone mineral 







Markers of inflammation and Adiposity related hormones 
Fresh Blood was collected after fasting for each participant of all five 
recruiting centers. Then was immediately centrifuged at 2000 x g for 10 
min at 4°C and separated into plasma and serum according to a 
standardized operating procedure. All the specimens were stored at -80 
°C until the time of analysis and sent to the project partners responsible 
for the analyses of the markers of inflammation and adiposity related 
hormones. Inflammatory and adiposity related markers were analyzed by 
a magnetic bead-based multiplex immunoassays (Bio-Plex) (BIO-RAD 
laboratories, Milan, Italy) according to the manufacturer’s instructions. In 
particular Interleukin 6 (IL-6), Interleukin 10 (IL-10), and Tumor Necrosis 
Factor alpha (TNFα) were measured in multiplex with Bio-Plex Pro 
Cytokine, Chemokine, and Growth Factor Assays (IL6 intra-assay 
coefficient of variation (CV), 4.01%; IL10 intra-assay CV, 3.99%; TNFα 
intra-assay CV, 4.55%); Transforming Growth Factor beta1 (TGF-β1 intra-
assay CV, 3.83%) with Bioplex Pro TGF- beta assay; Ghrelin (inter-assay 
CV, 2%) and Resistin (inter-assay CV, 4%) in multiplex with Bio-Plex Pro 
human diabetes assay. Plates were read and analyzed by Bio-Plex 
Manager Software. The level of Interleukin 6 receptor alpha (IL6rα, inter-
assay CV, 3.1%)), Glycoprotein 130 (gp130, inter-assay CV, 5.9%), 
Pentraxin-3 (inter-assay CV, 6.8%) and soluble TNFalpha receptors R1 
(TNF-R1, inter-assay CV, 6.1%) and R2 (TNF-R2, inter-assay CV, 7.7%) were 
assessed in multiplex in a subgroup of 569 samples with Bioplex Pro 
human inflammation assay (gp-130, inter-assay %CV 5.9). 
The quantitative determination of hsCRP, leptin, adiponectin has been 
performed by ProcartaPlexTM Immunoassay (eBioscience, Hatfield, UK) 
according to the manufacturer’s instructions. Analysis was performed 
using Luminex 200 instrumentation (Luminex Corportation, The 
Netherlands). Assay sensitivities were 19.31 pg/mL for Leptin, 4.39 pg/mL 




α1 Acid glycoprotein (AGP) has been measured by an 
immunoturbidimetric assay (AAGP2, Tina-quant α1-Acid Glycoprotein 
Gen.2 COBAS, Roche Diagnostic) with a measuring range of 0.1-4.0 g/L. 
Plasma albumin level was analyzed using the VITROS ALB slides (Ortho-




After testing the data distribution, according to Shapiro-Wilk test for 
Normality (p < 0.01) we decided to use non-parametric statistical tests. R 
studio (Version 3.3.3 for Windows) was used for the analysis and results 
are reported as mean and standard deviation (± SD Data were analyzed 
by non-parametric statistical tests, i.e. Mann - Whitney and Kruskal - 
Wallis tests, to determinate differences between males and females and 
between clusters (Santoro et al., 2018). To test differences between all 
pairs of clusters a pairwise comparison was used. A type I error of 0.05 
(p-value) in two-tailed tests was considered significant. To assess a 
possible linear association between the body composition variables and 
markers of inflammation we used the Pearson Product-Moment 
Correlation, after a natural log-transformation (ln) for BC variables and a 
log-odds transformation for markers of inflammation. Due to multiple 
testing of the variables, the Benjamini–Hochberg correction was applied 








Table 4.1 reported all the anthropometric and metabolic measures and 
body composition markers analyzed in 1121 subjects from the NU-AGE 
cohort. Almost all of those measures are significantly different between 
female (55%) and males (45%), for this reason all the analyses were 
conducted separately. Female have lower height, weight, waist 
circumference and waist to hip ratio, calorie intake, glucose and 
haemoglobin levels than males. Moreover, the fat mass markers of 
females are significantly higher, such as FM, FMI, FM/LM and android 
FM/LM but lower android/gynoid FM, while males have significantly 
higher lean mass markers than females in terms of LM, ALMI, LMI, SMI 
and also higher bone content markers in terms of BMC, BMD and T-score 
than females. In terms of inflammatory parameters elderly female have 
also significantly higher levels of ghrelin, leptin, adiponectin, resistin and 
AGP, but any difference emerged for IL6, Pentraxin 3, IL10, TGFb, TNFa, 
IL6ra, gp130, TNFaR1 and TNFaR2 circulatin levels (Supplementary 
material) than elderly males. 
 
Association of Body Composition with markers of inflammation and 
adiposity related hormones 
The pairwise scatter plot matrices in figure 4.1 and figure 4.2 reports all 
the correlations between BC parameter and inflammatory markers in 
female and males, respectively. In elderly female leptin ghrelin is 
significantly negatively correlated with BMI, FM, FMI, and FM/LM while 
is significantly positively correlated with SMI. Leptin show a strong (ρ > 
0.60, p-value < 0.05) significant positive correlation with BMI, FM, FMI, 
FM/LM, and a positive correlation with lean mass in terms of LMI and 




significant negative correlation with SMI. Adiponectin is significantly 
negatively correlated with BMI, FM, LM, LMI. While CRP and AGP are 
significantly positively correlated with BMI, FM, FMI, FM/LM, LMI and 
ALMI, while significantly negatively correlated with SMI. No significant 
correlation is reported for Resistin and Albumin with the body 
composition markers. 
Unlike female, in elderly men, ghrelin is only slightly correlated with SMI. 
While also in this case, leptin is significantly positively correlated with 
BMI, FM, FMI FM/LM, LM, LMI, BMC, BMD and T score, and significantly 
negatively correlated with SMI. Adiponectin is significantly negatively 
correlated with BMI, FM, FMI, LM, LMI, ALMI. CRP is significantly 
positively correlated with BMI, FM, FMI, FM/LM, while significantly 
negatively correlated with SMI. Albumin is significantly positively 
correlated with LMI, ALMI and SMI No significant correlation is reported 
for Resistin and AGP with the body composition markers. All the results 
are reported in figure 4.2. 
The upper left part of the pairwise scatter matrix plot in figure 4.1 and 
4.2 reported all the correlation of the BC parameters in female and males, 
respectively. As expected, all the fat mass, lean mass and bone markers 
are significantly correlated among themselves and SMI is negatively 
correlated with the fat mass markers BMI, FM, FMI, FM/LM and positively 
correlated with ALMI in both female and males.   
The lower right part of the pairwise scatter matrix plot in figure 4.1 and 
4.2 reported all the correlation of the inflammatory markers in female 
and males, respectively. In females, as expected, ghrelin is negatively 
associated with leptin while in males no significant correlation is 
reported. Moreover, leptin shows a negative correlation with adiponectin 
and a positive correlation with CRP in both females and males, while a 




is negatively related with adiponectin and positively with resistin only in 
females and with CRP in both genders.  
No correlation was found between the BC markers and the following pro- 
and anti-inflammatory markers in both female and male elderly: IL6, 
Pentraxin 3, IL10, TGFβ1, TNFa, IL6ra, gp130, TNFaR1 and TNFaR2. 
In addiction table 4.2 and table 4.3 reported a correlation matrix of 
android FM/LM and android/gynoid FM with markers of inflammation 
and adiposity for female and males, respectively. 
In elderly female ghrelin is significantly negatively correlated with android 
FM/LM and android/gynoid FM, otherwise leptin is significantly positively 
correlated with the same BC parameters in both males and females. 
Another negative correlation is between adiponectin and android FM/LM 
and android/gynoid FM in both females and males, while CRP and AGP 
are significantly positively correlated in both females and male and only 
in female, respectively. Albumin is significantly negatively correlated with 
android FM/LM and android/gynoid FM. No correlation was found 
between android FM/LM and android/gynoid FM and resistin, IL6, 
Pentraxin 3, IL10, TGFβ1, TNFa, IL6ra, gp130, TNFaR1 and TNFaR2 (Table 
4.2; Table 4.3). 
 
Association of markers of inflammation and adiposity related hormones 
with Body Composition Clusters 
As reported in chapter 3, inflammatory markers and adiposity related 
hormones have been evaluated among clusters of body composition 
markers (Santoro et al., 2018). Briefly, female and males were separately 
investigated and based on the BMI, FM, FMI, FM/LM, LM, LMI, ALMI, SMI, 
BMC, BMD and T-score five clusters have been identified for females 
(normal weight (NW), BMI=21.39; Overweight A (OWA), BMI=25.09; 




Low Obesity B (LOB), BMI=31.92) and six for men (normal weight (NW), 
BMI=23.98; Overweight A (OWA), BMI=25.69; Overweight B (OWB), 
BMI=26.27; Low Obesity A (LOA), BMI=30.06; Low Obesity B (LOB), 
BMI=30.42 and Moderate Obesity (MO), BMI=36.6). Those clusters can 
discriminate group of subjects with similar BMI but significantly different 
BC markers (Santoro et al., Frontiers in physiology). Figure 4.3 shows a 
significant difference among the five female clusters for ghrelin (p=5.297 
e-06), adiponectin (2.829 e-06), CRP (1.154e-12), leptin (p<2.2e-16), AGP 
(1.651e-12) and TGFβ1 (p= 0.005). Indeed, NW cluster shows higher levels 
of ghrelin compared with OWB and LOB clusters, and also OWA cluster 
has significant higher levels than LOB cluster (Figure 4.3). Leptin levels are 
different among all the five clusters, in particular are lower in NW cluster. 
Interestingly the two cluster with similar BMI (LOA and LOB) have 
different leptin levels, higher in LOB cluster than LOA (Figure 4.3B). Also, 
adiponectin levels are higher in NW females cluster compared with OWA, 
LOA and LOB, females in the OWA cluster have lower levels of adiponectin 
than OWB but higher than LOA and females in the OWB cluster have 
significantly higher levels than females in LOA and LOB (Figure 4.3C). NW 
female cluster shows lower levels of CRP compared with all the other four 
clusters, and OWA cluster have lower levels of CRP compared with LOA 
and LOB and those in cluster OWB have lower levels than LOA and LOB 
(Figure 4.3D).  NW cluster has the lower levels of AGP compared with all 
the other four clusters, moreover, cluster OWA has lower AGP levels 
compared with OWB, LOA and LOB, and the levels of AGP are lower in 
OWB cluster compared with LOA and LOB (Figure 4.3E). While the only 
significant difference of TGFβ1 levels among the five female clusters is 
between NW and LOB (Figure 4.3F). 
Figure 4.4 shows a significant difference among the six males clusters for 
ghrelin (p=0.0006417), adiponectin (p= 0.0005453), CRP (p=1.174e-06), 




particular, ghrelin levels are significantly higher in NW cluster compared 
with LOB (Figure 4.4A). NW cluster shows lower levels of leptin compared 
with OWB, LOA, LOB, MO. Leptin levels are significantly lower in OWA 
cluster compared with OWB, LOA, LOB and MO, cluster OWB has 
significantly lower leptin level than LOA, LOB and MO, while males in LOA 
cluster have lower leptin levels than LOB and MO and males in cluster 
LOB have lower leptin levels than MO (Figure 4.4B). NW males cluster 
shows higher levels of adiponectin compared with the LOB cluster (Figure 
4.4C). CRP and AGP levels are significantly lower in elderly men comparing 
NW and LOB clusters, OWA and LOB clusters, OWB and LOB clusters 
(Figure 4.4D and 4.4E). While the only significant difference of albumin 







The present study reports evidence for the association between BC 
markers and the levels of different pro- and anti-inflammatory 
parameters and adiposity related hormones. 
1121 healthy European elderly men and women who participated in the 
European project NU-AGE have been analyzed. As expected, major 
differences exist between BC characteristics in elderly women and men. 
In particular, elderly females have higher values in fat mass indices than 
males while males have higher values of lean mass indices and bone 
content than elderly females. Sex dimorphism in total BC is present since 
birth and continues in adulthood. Males maintain their level of lean mass 
into the age of 50, but then begin to lose muscle mass due to both 
hormonal changes and lower physical activity. Also females show a similar 
decrease in lean mass, but they often show greater increase in fat mass 
(Wells JCK, 2007), even when weight is stable (Zamboni et al., 2003). Such 
changes continue into old age (Bazzocchi et al., 2013; Diano et al., 2017). 
Among the adiposity related markers, a significant negative association 
between ghrelin and fat mass has been found in females but not in males, 
while a positive association with SMI has been highlighted in both 
genders. Studies have demonstrated that ghrelin levels can decreased in 
obesity, its levels are mainly influenced by changes in energy balance, in 
fact insulin may play an important role in the decrease of ghrelin levels 
after meals (Murdolo et al., 2003). Even if no significant differences 
emerged for BMI and insulin between genders, as seen females have 
greater fat mass than men, and this could explain the different 
association found in ghrelin levels. In addition, comparing ghrelin levels 
among the female and males’ clusters previously identified in chapter 3 
(Santoro et al., 2018 a) which differs for BMI and fat, lean and bone 
masses a gender difference emerged. Indeed, a significant negative 




found, ghrelin levels decreased from NW cluster (lower BMI) to LOB 
cluster (higher BMI), while in males this trend is not significant. 
A significant positive association between fat mass, lean mass and bone 
mass markers and leptin levels has been found, while SMI is negatively 
associated in both males and females. Leptin is an adipokine secreted by 
adipocytes, generally increases with weight gain, and decreases with 
weight loss (Spiegelman BM and Flier JS, 2001), but has been 
demonstrated that leptin is also produced by skeletal muscle (Fernández-
Real et al., 2000; Wolks et al., 2012) as well as bone cells (Thomas T, 
2004). Leptin treatment increases muscle mass and decreases the 
expression of atrophy-related factors such as myostatin, muscle RING-
finger protein-1 (MuRF1), and muscle atrophy F-box (MAFbx) in muscle 
(Hamrick MX, 2017). Different studies highlight that the effects of leptin 
on the skeleton are quite complex, and that lower levels of leptin are 
associated with low bone mass primarily due to reduced cortical bone 
(Hamrick et al., 2008 a; Hamrick et al., 2008 b). In fact, central infusions 
of leptin in leptin-deficient ob/ob mice increase cortical bone formation 
and total bone mass (Bartell SM et al., 2011). Moreover, it has been 
demonstrated than osteoporotic subjects have lower levels of leptin in 
the bone marrow microenvironment (Pino et al., 2010).  
Adiponectin, together with leptin, is able to regulate the energy 
homeostasis. Studies have demonstrated that adiponectin levels can 
decreased in obesity and insulin resistance (Mancuso P, 2016). In the 
1121 subjects analyzed no correlation was found between adiponectin 
and bone markers, while an inverse relationship emerged with fat and 
lean markers in both males and females. However, our results concord 
with a recent paper by Baker and colleagues demonstrating that in elderly 
high levels of serum adiponectin are significantly correlated with low BMI, 
fat and lean mass BC markers (Baker et al., 2018)(Baker et al., 2018)(Baker 




adiponectin levels decrease as increase BMI. However, it is interesting to 
note that among the five clusters of females, the two clusters with similar 
BMI (25.09 and 26.62 respectively) have different adiponectin levels, 
higher ones are in the overweight group characterized by higher levels of 
fat and bone mass and lower levels of lean mass, indeed, a similar trend 
can be found among the two low obesity clusters (BMI 31.48 and 31.92 
respectively) even if it is not significant. While the only significant 
difference of adiponectin levels among the six male clusters is between 
the low obesity B cluster and the normal weight which have higher levels 
and an increasing trend emerged when comparing the two clusters 
(overweight A vs B and low obesity A vs B) with similar BMI but different 
amount of fat, lean and bone mass.  
Regarding inflammatory markers, a significant positive correlation 
between CRP and fat mass markers emerged while there is a negative 
association with SMI in both females and males. CRP and AGP are 
positively correlated with lean mass markers in female. In addition, AGP 
is positively correlated LMI and negatively associated with SMI in female, 
while in male the only significant association between AGP levels and BC 
markers is a positive correlation with android/gynoid FM ratio. A negative 
association between albumin and central adiposity markers (android 
FM/LM and android/gynoid FM ratio) has been found in females while in 
males, albumin is positively associated with lean mass markers (LMI, ALMI 
and SMI). Different studies had demonstrated that an increase in fat mass 
is correlated with markers of inflammation in elderly (Brinkley et al., 
2012; Schrager et al., 2007). The obesity-related inflammation and its 
mechanisms are not entirely understood, expansion of adipose tissue is 
mainly influenced by changes in energy balance which may play a major 
role. The expansion of adipose tissue leads the activation of macrophage 
to secrete inflammatory cytokines such as TNFα and IL-6 (Kern et al., 




in the setting of obesity (Matarese et al., 2005) along with resistin, 
whereas adiponectin and ghrelin have anti-inflammatory properties. 
Indeed, adiponectin inhibit inflammation by blocking NF-kB activation 
and reducing cytokines like TNFα, IL-6, and IL-18 (Yamaguchi et al., 2005; 
Chandrasekar et al., 2008). In addition, adiponectin plays a pro-
inflammatory role in arthritic joints by promoting COX2 expression and 
PGE2 synthesis, which are related to an increase in inflammation and pain 
(Bas et al., 2014). Through the efflux of anti-inflammatory and pro-
inflammatory adipokines into the systemic circulation, adipose tissue 
plays an important role in regulating the inflammatory response in the 
setting of caloric restriction, obesity, and aging. However, it is possible 
that the association with inflammatory markers differs depending on 
gender and adipose tissue location. The two most commonly measured 
inflammatory proteins in nutritional investigations are CRP and AGP, 
which are measures of acute and chronic inflammation, respectively 
(Suchdev et al., 2017). Our results show that there is a positive correlation 
between CRP and fat mass in both genders, but LMI and ALMI correlate 
only in female. Moreover, in females’ clusters CRP and AGP increased 
with BMI and a similar trend can be seen also in males’ clusters. It was 
demonstrated that significant differences in the effect of aging on the 
human immune system emerged between female and males, with a 
stronger pro-inflammatory response in female (Marttila et al., 2013). No 
differences emerged in CRP levels between males and females (median 
0.84 mgL-1 and 0.87 mgL-1, respectively), however, females have a 
significative higher concentration of AGP compared to males (median 
0.67 gL-1 and 0.61 gL-1, respectively). Moreover, AGP shows a positive 
correlation with fat mass and LMI in female. Differences in haemoglobin 
levels, which is lower in females than in males (median 13.7 gdL-1 and 
14.9 gdL-1, respectively), could contribute to the different inflammatory 




positive and negative acute phase reactants. This seems to provide a 
relation to the increased inflammatory state in elderly females. Different 
studies had demonstrated an association between the specific pattern of 
increased CRP and decreased albumin concentrations with sarcopenia, 
frailty and vascular and non-vascular mortality in elderly subjects (Clarke 
et al., 2008; Hubbard et al., 2009). Even if no correlation has been found 
between BC markers and indexes and circulating levels of a series of pro- 
and anti-inflammatory molecules such as IL6, Pentraxin 3, IL10, TGFβ1, 
TNFα, IL6rα, gp130, TNFαR1 and TNFαR2, there are evidence that there 
are association between fat mass, BMI and waist circumference and 
inflammatory markers (Brinkley et al., 2012; Schrager et al., 2007; Cesari 
et al., 2005). TGFβ1 in females increase with BMI and this can be 
explained by the size of the cohort used, by the technique used to identify 
BC and many other factors. The strength of this study is the size of the 
sample used for the analysis, consisting of healthy elderly subjects aged 
between 65 and 79, who are representative of the European population. 
Moreover, DXA, which is used for the assessment of BC, is a powerful and 
comprehensive tool and a gold-standard technique at this level. A 
limitation can be associated with the voluntariness of subjects to 
participate to the NU-AGE study, in fact, in all the five countries 
considered the participants represent a population that is particular 
interested in health and nutritional aspects and as this it has higher 
knowledge on these issues than the general population at the same age. 
On the whole, all the BC markers studied in this paper are positively or 
negatively associated with adipose related and inflammatory markers, 
excepted SMI which represents a marker of sarcopenia, together with 
ALMI (Kim et al., 2016; Guglielmi et al., 2016). Our results show that SMI 
association with adiposity related and inflammatory markers are always 
discordant in both females and males except for the positive correlation 




is positively correlated with an anti-inflammatory molecule, i.e. ghrelin, 
while negatively associated with leptin, CRP and AGP which are 
considered pro-inflammatory markers. In elderly sarcopenia is related 
with a higher increase of inflammatory status, therefore the results 
obtained with SMI are more reliable respect of results highlight with ALMI 
when both are considered as markers of sarcopenia. These results fit with 
the open debate on the use of optimal quantitative markers of sarcopenia 
(Kim et al., 2016). Moreover, a negative association between SMI and BMI 
and fat mass markers and positive association with ALMI but not with LM 
and LMI have been identified, while ALMI is positively correlated with BMI 
and fat mass markers an also with LM and LMI. These results showed that 
it is likely that ALMI still represents the general lean mass instead of being 









n = 620 
Male 
n = 501 
p-value q-value 
Age (years) 70.7 ± 3.9 71.0 ± 4.1 NS NS 
Weight (kg) 67.7 ± 11.2 80.6 ± 12.6 <2.2e-16 <2.2e-16 
Height (cm) 160.0 ± 6.7 173.0 ± 6.4 <2.2e-16 <2.2e-16 
BMI (kg/m2) 26.5 ± 4.1 26.9 ± 3.7 1.16e-02 NS 
Hip circumference (cm) 103.3 ± 9.1 101.5 ± 7.6 1.32e-03 NS 
Waist circumference (cm) 86.9 ± 10.8 96.7 ± 11.1 <2.2e-16 <2.2e-16 
Waist/Hip ratio 0.85 ± 0.31 0.95 ± 0.06 <2.2e-16 <2.2e-16 
Calorie intake (kcal) 1680.9 ± 328 2123.3 ± 445 <2.2e-16 <2.2e-16 
Physical activity (Pase Score) 127.8 ± 48.9 140.9 ± 59.5 3.53e-04 NS 
Metabolic parameters     
Glucose 5.52 ± 0.77 5.85 ± 0.95 7.92e-11 1.54e-07 
Insulin 8.75 ± 5.57 10.03 ± 7.85 NS NS 
HOMA IR 2.21 ± 1.58 2.70 ± 2.36 5.47e-03 NS 
HOMA beta 90.43 ± 52.88 89.06 ± 63.57 2.08e-02 NS 
Haemoglobin (g/dL) 13.7 ± 0.9 14.9 ± 1.0 <2.2e-16 5.66e-14 
Body composition markers     
FM (kg) 26.2 ± 8.06 22.0 ± 8.37 <2.2e-16 <2.2e-16 
FMI (kg/m2) 10.3 ± 3.16 7.35 ± 2.74 <2.2e-16 <2.2e-16 
LM (kg) 40.3 ± 4.97 57.1 ± 6.71 <2.2e-16 <2.2e-16 
ALMI (kg/m2) 6.56 ± 0.77 8.47 ± 0.87 <2.2e-16 <2.2e-16 
LMI (kg/m2) 15.7 ± 1.53 19.1 ± 1.80 <2.2e-16 <2.2e-16 
FM/LM 0.65 ± 0.19 0.39 ± 0.14 <2.2e-16 <2.2e-16 
SMI  0.25 ± 0.03 0.32 ± 0.04 <2.2e-16 <2.2e-16 
BMC (g) 2092 ± 357 2948 ± 483 <2.2e-16 <2.2e-16 
BMD (g/cm2) 1.03 ± 0.11 1.19 ± 0.11 <2.2e-16 <2.2e-16 
T-score -0.82 ± 1.20 -0.19 ± 1.20 < 2.2e-16 4.92e-14 
Android/Gynoid FM* 0.50 ± 0.15 0.78 ± 0.21 <2.2e-16 <2.2e-16 
Android FM/LM* 0.79 ± 0.30 0.61 ± 0.25 2.70e-16 4.92e-13 
Inflammatory parameters     
Ghrelin (pg/ml) 1631 [842 - 4427] 1256 [582 - 3538] 9.86e-05  
Leptin (ng/ml) 4.39 [2.86 - 6.21] 1.86 [0.94 - 3.16] <2.2e-16 <2.2e-16 
Adiponectin (µg/ml) 14.09 [9.76 - 19.96] 7.33 [5.03 - 10.51] <2.2e-16 <2.2e-16 
Resistin (pg/ml) 5850 [4287 - 752] 6222 [4756 -   8310] 5.67e-03  
CRP (mg/L) 0.87 [0.44 - 1.72] 0.84 [0.41 - 1.78] NS NS 
AGP (mg/ml) 0.67 [0.57 - 0.79] 0.61 [0.51 - 0.73] 1.24e-08 2.32e-05 




Table 4.2 | Correlation Matrix for android Fat Mass/lean Mass and android/Gynoid Fat mass 
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1              
Resistin .08 .04 -.09 .17
* -.10 1             
CRP .28
*** .22** -.17 .24*** -.16 .12 1            
AGP 
.32*** .31*** -.12 .27*** 
-
.28*** 




-.21** .09 -.06 .00 -.08 -.08 .00 1          
IL-6 -.05 -.02 .30
*** -.13 -.03 -.07 .03 .07 .01 1         
IL-6 ra .00 .01 .10 .09 .02 .19 -.02 -.02 -.10 -.12 1 
       
GP-130 .02 -.02 -.01 .08 .10 .11 -.05 -.11 -.13 -.14 .70
*** 1       
Pentraxin-3 .09 .00 -.20 .11 .14 -.02 .01 .00 -.11 -.09 .42
*** .63*** 1      
TNF α .04 .04 .28
*** -.05 .00 -.12 .03 .02 .01 .63*** -.12 -.11 -.12 1     
TNF R1 .19 .10 -.05 .24
* -.04 .25** .08 .08 -.14 -.11 .65*** .78*** .52*** -.07 1    
TNF R2 .20 .12 .01 .22 .01 .23
* .13 .07 -.19 -.05 .68*** .77*** .57*** -.04 .83*** 1   
IL-10 -.03 -.01 .30
*** -.11 .03 -.08 -.01 -.01 .02 .63*** -.09 -.07 -.13 .64*** -.04 .00 1  
TGF β 



























Table 4.3 | Correlation Matrix for android Fat Mass/lean Mass and android/Gynoid Fat mass 
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ANDR/GYN 
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Ghrelin -.15 -.10 1 
               
Leptin .76









1              
Resistin -.01 .05 -.03 .03 -.04 1 
            
CRP .30
*** .30*** -.06 .25*** -.16 .10 1            
AGP .20 .22
* .04 .13 -.15 .12 .45*** 1           
Albumin -.19 -.12 .07 -.05 -.01 -.05 -.14 -.04 1 
         
IL-6 .08 .08 .35
*** -.02 .02 .04 .22*** .22** -.05 1         
IL-6 ra -.01 -.06 .05 .03 .05 -.02 -.10 -.07 -.08 -.12 1 
       
GP-130 -.11 -.15 -.03 -.07 .14 -.03 -.15 -.05 -.04 -.08 .72
*** 1       
Pentraxin-3 -.11 -.12 -.21 -.11 .19 -.07 -.08 .01 -.06 -.08 .57
*** .70*** 1      
TNF α -.02 .00 .41
*** -.11 -.02 .01 .03 .08 .04 .64*** -.09 -.01 -.16 1     
TNF R1 -.02 -.04 .03 .01 .00 .16 .02 .06 -.12 .00 .64
*** .77*** .61*** .03 1    
TNF R2 .03 -.01 .06 .07 .06 .19 .02 .08 -.16 .03 .66
*** .76*** .63*** .01 .85*** 1   
IL-10 .02 .03 .32
*** -.09 .00 .03 .01 .10 -.08 .51*** .07 .09 -.04 .66*** .09 .12 1  
TGF β 
.09 .08 -.11 -.01 .02 .12 .02 .07 -.02 .03 
-
.37*** 















Figure 4.1 | Pairwise scatter plot matrix. histogram and correlation coefficients of all 
Body Composition parameters and Inflammatory parameters in female.  Pairwise scatter 
plots are in lower triangle boxes, histograms are in the diagonal boxes and correlation 





Figure 4.2 | Pairwise scatter plot matrix. histogram and correlation coefficients of all 
Body Composition parameters and Inflammatory parameters in Male. Pairwise scatter 
plots are in lower triangle boxes, histograms are in the diagonal boxes and correlation 
















5. BODY COMPOSITION AND FRAILTY 
 
This Chapter reports on data not yet published. 
 
5.1 INTRODUCTION 
Human aging is an inevitable and irreversible biological process, although 
with the improvement of lifestyle and health care, there has been an 
increase in average life span. A recent study from Eurostat (Eurostat, 2020 
b) shows that the European union’s population will decrease by 7% 
between 2019 and 2100. However, people aged 65 years and over will 
increase from 20% in 2018 to 31% in 2100 (Figure 5.1).  
 




However, the effects of the Covid-19 outbreak on mortality could change 
this trend. Indeed, if we analyzed mortality data of 2020 the number of 
deaths across the 31 European countries starts to rise abruptly at the 
beginning of March, in week 10, compared to previous years (average 
over 2016 to 2019) (Eurostat, 2020 c). In Italy, as in other European 
countries, the epidemic has hit vulnerable people hardest, and the 
increase in mortality is greatest in the 65-79 age group, for both men and 
women (Istat, 2020). The reasons for such an increased susceptibility are 
still matter of debate, however, it is clear that comorbidities (including 
diabetes and cardiovascular diseases) are strong risk factors for severe 
forms of Covid19. As a whole, it appears that the elderly population is at 
risk because two possible main reasons: comorbidities and increased 
inflammatory reactions (inflammaging), two phenomena that usually 
accompany the aging process. In fact, one of the most universal features 
of the ageing process appears to be a chronic, low-grade inflammatory 
state indicated inflammaging (Franceschi et al., 2007; Cevenini et al., 
2013) that is associated with increased risk of age-related diseases 
(Franceschi and Campisi, 2014; Ferrucci and Fabbri, 2018). 
In particular, inflammaging is marked by a complex reshape in the 
production of pro- and anti-inflammatory mediators, which, as a whole, 
tilts the balance toward an increase of the level of basal inflammation. As 
an example, aging is characterized by a decreased production of the anti-
inflammatory interleukin 10 (IL-10) and an increase of the pro-
inflammatory interleukin 6 (IL-6), (Marcos-Pérez et al., 2020), this one in 
particular is considered a risk factor for many of the major age-associated 
diseases, including obesity, cardiovascular diseases, sarcopenia and 
frailty (Santoro et al., 2020). Even if many studies have shown a positive 
correlation between frailty and inflammatory parameters, such as IL-6 or 
C reactive Protein (CRP), no single predictive molecular markers have 




Frailty is a condition of decreased capability to cope with and recover 
from stresses even of mild intensity. As already mentioned in Chapter 1, 
frailty is a strong predictor of disability, hospitalization and mortality and 
a criterion for non-eligibility for invasive treatments. The Frailty 
phenotype described by Fried and colleagues (Fried LP et al., 2001) 
includes involuntary weight loss, exhaustion, low physical activity, low 
gait speed, and low grip strength and is considered a “physical” frailty. At 
variance, the Frailty Index includes anomalous laboratory results or 
presence of diseases and it is considered as a measure of decline in health 
(Rockwood, Mitnitski, 2007). According to the standardized phenotype 
proposed by Fried and colleagues, frailty is defined by verifying if three or 
more out of the five criteria are met. People can be divided in three 
different groups: non-frail (none of these criteria are met), pre-frail (one 
or two features are met) and frail (three or more criteria are met). The 
prevalence of frailty in EU’s population aged 65–74 years old is about 
6.0% while pre-frail subjects are 41.7%, moreover the prevalence 
increases with age with 16.0% of frail and 50.5% of pre-frail for people 
between 75 and 84 years old (Manfredi et al., 2019). Furthermore, it has 
been demonstrated that excess visceral adipose tissue (VAT) rather than 
accumulation of subcutaneous adipose tissue (SAT) represents the cause 
of atherosclerotic cardiovascular events (Sato et al., 2018) and an 
elevated waist circumference and body fat mass are risk factors for frailty 
in the elderly (Xu Et al., 2020). The connections between BC and frail 
status are largely unexplored, with particular regards for parameters 
related to inflammaging. The aim of this third study was to detect 
differences of body composition and health markers that characterize 
pre-frail or frail individuals. In addition, through regression analysis we 
define a “frailty signature”. To fulfill this objective, Italian Non-frail and 
Pre-frail subjects from the NU-AGE Project were selected while Italian 





Study design and population 
Within the framework of the European NU-AGE project – New dietary 
strategies addressing the specific needs of elderly population for a 
healthy ageing in Europe (Grant Agreement no. 266486, Coordinator 
Prof. Claudio Franceschi, registered at clinicaltrials.gov as NCT01754012) 
2668 free-living elderly people, aged between 65 and 79 y.o., free of 
major diseases and competent to make own decision, were selected 
within five European countries (Italy, UK, France, Poland and The 
Netherlands). After testing the exclusion criteria, i.e. included severe 
heart diseases, type 1 and insulin-treated type 2 diabetes, chronic use of 
corticosteroids, recent use of antibiotics or vaccinations, change in 
habitual medication use, malnutrition (body mass index <18.5 kg/m2 or 
10% weight loss within 6 months), or food allergy/intolerance requiring 
special diets, 1296 were eligible to participate. 
Moreover, the presence of frailty (Fried et al., 2001) was one of the 
exclusion criteria in the NU-AGE project, as the aim was to include healthy 
elderly (Berendsen et al., 2014). 
So, in collaboration with the Nestlé Institute of Health Sciences (NIHS) 
from Lausanne (Switzerland), one of the partners of the NU-AGE study, a 
new project has been defined and funded to recruit frail subjects, named 
PRO-AGE: “Omics for Aging-ProAGE” (n. 14.02. NIHS Code NPDI n. DUND-
100373). PRO-AGE uses the same protocol as NU-AGE for the recruitment 
of subjects, the age is between 65 and 79 years and it has been run in Italy 
(Bologna). Frailty has been assessed using the standard phenotype 
proposed by Fried et colleagues and verifying the presence of at least 3, 
or more, criteria. Given that the 23 PRO-AGE subjects were recruited in 
Italy, we decided to only include in our study the 271 NU-AGE Italian 




baseline, and were included from the NU-AGE and PRO-AGE studies 
cohorts, N= 271 and N = 21 (after removing two drop-out), respectively. 
NU-AGE was approved by the Ethics Committee of the coordinator 
center: the Independent Ethics Committee of the S. Orsola-Malpighi 
Hospital Bologna (Italy), and by the local/national Ethics Committees of 
all the other four recruiting centers: the South-East 6 Person Protection 
Committee (France), the Wageningen University Medical Ethics 
Committee (Netherlands), the National Research Ethics Committee–East 
of England (UK), and the Bioethics Committee of the Polish National Food 
and Nutrition Institute (Poland). PRO-AGE was also approved by the 
Independent Ethic Committee of the S. Orsola-Malpighi Hospital Bologna 
(Italy). 
 
Assessment of Body Composition 
A whole-body DXA scan has been carried out to measure total and 
regional BC using the fan-beam densitometer Lunar iDXA, GE Healthcare, 
Madison, WI, USA – enCORETM 2011 software version 13.6 (Bologna, 
Italy); The scanner was calibrated daily using a standard calibration block 
supplied by the manufacturers following standard Quality Control 
procedures. DXA scans were performed by trained technicians according 
to state-of-the-art technique and manufacturers recommendation.  
No metal items were present during densitometry. Participants were 
positioned in the center of the scanning field in a supine position with the 
arms at sides and separated from the trunk. As mentioned, 
measurements of total-body and standard regional body composition, 
such as trunk, upper limbs, android and gynoid region were defined by 
DXA. For each region, DXA scanned the weight (in g) of total mass, FM, 
non-bone LM, and BMC. The weight (in g) of total mass, whole body fat 




content (BMC). Specific indices have been used as reported in Table 1 of 
third chapter. The indexes of total body FM/LM, FMI, and LMI are 
considered markers of general mass, android/gynoid FM is related of 
central/peripheral distribution of FM, while the FM/LM android, and 
ALMI and SMI indices are markers of central abdominal distribution, low 
muscle mass respectively. Bone mineral density (BMD) and T-score were 
also considered as markers of bone health. Moreover, DXA has 
embedded algorithms to specifically estimate the amount of VAT and SAT 
in the android region (Ponti et al., 2020; Bilsborough et al., 2014). 
 
Data Collection 
Height was measured with a stadiometer to the nearest 0.1 cm. Weight 
was measured to the nearest 0.1 kg with a calibrated scale while wearing 
light clothes. Body Mass Index (BMI) was calculated as weight 
[kg]/height[m]2. All measures were taken by trained research assistants. 
Plasma total, HDL and LDL cholesterol (mg/dL) and triglycerides (mg/dL) 
were measured with standard methods.  
Concentrations of parathyroid hormone (PTH) in all serum samples was 
measured with an ELISA kit (intact PTH; MD Biosciences Inc.). Intra-assay 
and inter- assay CVs were 3.0% and 5.1%, respectively (at a concentration 
of 47.7 and 52.6 pg/ml, respectively).  A 24-h urine collection was 
obtained for estimation of sodium, potassium, urea and creatinine 
excretion. The first urine of the day was discarded and all urine over the 
following 24h were collected. Urinary sodium and potassium were 
measured by direct potentiometry assay, Olympus AU400 chemistry 
analyzer by Beckman and urinary creatinine was measured by 
colorimetric method based on the Jaffe reaction. Glycated haemoglobin 




insulin (mcU/mL), were measured on frozen blood and frozen urine (urea) 
in a centralized centre with standard methodologies. 
Dietary intake was assessed by means of validate version of the 7-day 
food records completed by the participants (Ortega et al., 2015). 
Consumed foods were converted using a software exploiting local food 
composition tables: INRAN and IEO. The variability of the food 
composition was assessed analyzing calories and nutrients of 16 basic 
foods, i.e. semi-skimmed meal, egg, apple, orange, chicken, breast, beef 
filet, salmon, tomatoes, peas, nuts, potatoes, lager beer, red brown 
whole meal, spinach, extra-virgin olive oil).  
 
Statistical analyses 
After testing the data distribution, according to Shapiro-Wilk test for 
Normality (p < 0.01) we decided to use non-parametric statistical tests.  
Characteristics of the studied population and sub-groups were analyzed 
using Kruskal - Wallis tests or Fisher’s exact tests for numerical or 
categorical data, respectively. R studio (Version 3.3.3 for Windows) was 
used for the analysis and results are reported as mean and standard 
deviation (± SD). Because of the 85% of the frail subjects present in the 
PRO-AGE cohort were females we decided to focus our analyses only on 
women, in order to avoid sex biases. The significant BC markers plus age 
and Neutrophils, mean corpuscular hemoglobin (MCH), mean 
corpuscular hemoglobin concentration (MCHC), white blood cells (WBC) 
and Urinary Nitrogen were used to build a multinomial logistic regression. 
In order to reduce multicollinearity, i.e. the presence of correlation 
between predictors that can cause less precise estimates, the Spearman's 
rank correlation coefficient was used to determinate correlation between 
variables and the most correlated were eliminated one by one to reduce 




used to test multicollinearity and only predictors with VIF < 2 were 
included in this model. Because of the relatively small sample size in sub-
groups, a cross-validation technique was used to ensure that the 
multinomial logistic regression models were robust. The dataset was 
iteratively randomly split into a training set, to fit the model, and a test 
set, to evaluate it, with the “Leave-one-out cross-validation” (LOOCV). 
The cross-validation has a single hyperparameter “k” that controls the 
number of splits of the dataset into train and test sets, in the LOOCV k is 
the number of examples (Figure 5.2), for this reason has the maximum 
computational cost and it is appropriate for small datasets. 
 
 
Figure 5.2 |Example of iterations of cross-validation, the sample is split into a training 
and test set. 
 
The prediction model performance was evaluated using a confusion 
matrix and area under ROC curves (AUC) (Xia et al., 2013) [R package 







Table 5.1 reported all the anthropometric measures and body 
composition markers analyzed in 292 Italian subjects from the NU-AGE 
and PRO-AGE cohorts. Differences among Non-Frail, Pre-Frail and Frail 
subjects are significant for anthropometric measures: frail subjects have 
higher weight, BMI, waist and hip circumference than the other two 
groups, while height is lower in frail subjects and waist to hip 
circumference ratio is not different among the three groups. BC 
parameters highlight a higher presence of fat mass markers in frail subject 
with significant differences compared to non-frail and pre-frail in terms 
of FM, FMI, FM/LM, android FM/LM and gynoid FM/LM. Non-frail 
subjects have significantly higher lean mass markers in terms of LM and 
SMI and also higher BMC.  
As expected, the Frail group is represented for the 85.7% of female 
subjects, the prevalence of frailty is indeed higher in women when 
compared with men (9,1 % and 6.0%, respectively) (Manfredi et al., 
2019). For this reason, we decided to analyze females apart. Table 5.2 
reported the anthropometric measures and body composition markers 
analyzed in 158 Italian female subjects from the NU-AGE and PRO-AGE 
cohorts. As for the whole Italian group, differences among Non-Frail, Pre-
Frail and Frail female subjects are significant for anthropometric 
measures and BC parameters. In particular, frail subjects have a 
significantly higher weight, BMI, waist and hip circumference, while no 
difference emerged for waist to hip circumference ratio. Moreover, frail 
subjects have significantly higher fat mass markers, such as FM, FMI, 
FM/LM, Android/Gynoid FM, Android FM/LM, Gynoid FM/LM, VAT and 
SAT but also higher lean mass markers in terms of LMI and ALMI. While 
SMI, which represents a marker of sarcopenia (Kim et al., 2016; Guglielmi 
et al., 2016) is lower than the other two groups. The mean cell volume 




the other two groups while white blood cells (WBC), neutrophils and 
nitrogen were significantly higher. No differences emerged for Total 
Cholesterol, HDL, LDL, Triglycerides, Glucose and Insulin, while PTH is 
significantly lower in frail subjects (Table 5.3). The significant BC markers, 
with the exception of PTH, which was measured in a subgroup of subjects, 
plus age and Neutrophils, MCH, MCHC, WBC and Urinary Nitrogen were 
studied to build a multinomial logistic regression. Figure 5.3 reports the 
correlation matrix based on Spearman's rank correlation. Orange circles 
highlights negative significant correlations, while violet ones refer to 
significant positive correlations among variables. As expected, all the fat 
mass, lean mass and bone markers are significantly correlated among 
themselves and SMI is negatively correlated with the fat mass markers 
such as BMI, Waist and Hip Circumference, FM, FMI, FM/LM, while there 
is no correlation with LMI and ALMI. Obviously, MCV and MCH were 
positively correlated as well as WBC and Neutrophils. As mentioned, the 
presence of correlation between predictors can cause multicollinearity 
and less precise estimates, so the most correlated variables (ρ < 0.65) 
were excluded one by one to reduce redundant information.  Age, ALMI, 
SMI, SAT, MCV, WBC and Urinary Nitrogen were used to build a 
multinomial logistic regression. The best reduced model included age, 
SAT, MCV and urinary nitrogen (Table 5.4). To evaluate the performance 
of this model, the AUC, i.e. Area under the ROC curve, was computed with 
a prediction capacity of 0.83 and accuracy of 0.74. In particular, table 
shows the sensibility (%) and specificity (%) of the classification for Non-







The present study reports evidence of the presence of differences among 
non-frail and pre-frail subjects and frailty ones.  
271 healthy non-frail and pre-frail Italian elderly who participated in the 
European project NU-AGE and 21 Italian frail participants of the PRO-AGE 
project have been analyzed. As expected, major differences exist 
between BC characteristics in elderly frails. It has been shown that BMI 
and obesity are associated with increased risk of frailty in the elderly 
(Blaum et al., 2005; Sewo et al., 2016), this is confirmed by our results in 
both all Italians and the subgroup of females. Though BMI has always 
been considered a valid tool to assess overall adiposity, it fails to 
distinguish between the relative contribution of fat mass and lean mass 
(Blundell et al., 2014).  Frail women have higher LMI values than the other 
two groups, this may be due to the fact that this group have a higher 
weight than non-frail or pre-frail women. In fact, despite higher values of 
LMI, the ratio of FM to LM turns out to be significantly higher in frail 
elderly women. Moreover, the frail group have significantly lower level of 
SMI, which represents a marker of sarcopenia (Kim et al., 2016; Guglielmi 
et al., 2016), the combination of high levels of FM and low levels of SMI 
is more associated with health risk and disability than individual 
conditions (Roubenoff et al., 2004). SAT and VAT were correlated with 
multiple metabolic risk factors (Fox et al., 2007), as expected our results 
reported high level of VAT and SAT for the frail group, in addition SAT 
seems to be a valid predictor of frailty in elderly female. 
The inclusion and exclusion criteria in the NU-AGE and PRO-AGE projects 
allowed to select healthy subjects, as a result all urinary and blood 
markers are within the range, although, as shown in the results, there are 
differences for frail subjects. Low levels of haemoglobin are often 
associated with low muscle strength or fatigue in frail individuals (Roy et 




have the lowest values. In addition, it has been demonstrated that Frailty 
is associated with higher numbers of neutrophils and monocytes in both 
males and female (Samson et al., 2019), in accordance with our results. A 
recent review highlights that different studies have demonstrated a 
correlation between increased levels of parathyroid hormone (PTH) and 
frailty while other studies have found that there was no relationship 
(Saedi et al., 2019). In fact, our results reported significant lower level of 
PTH for frailty subjects.  
As expected, the Frail group is represented for the 85.7% of female 
subjects, the prevalence of frailty is indeed higher in women when 
compared with men (9,1 % and 6.0%, respectively) (Manfredi et al., 
2019).  
However, body composition parameters and urinary and blood markers 
do not allow discrimination between pre-frail and non-frail or frail 
females. In fact, all the 25 non-frail subjects of the test set were classified 
correctly, as well as the 5 frail subjects, while all the 10 pre-frail subjects 
were classified as non-frail. Despite the Fried et al. scale is the most used, 
the presence of some components of this phenotype, i.e. low hand grip 
strength or low gait speed, are more relevant than others. This may affect 
the correct detection of the pre-frail subject, in fact a systematic review 
by Fernandez-Garrido et al. (2014) show that the prevalence of pre-frailty 
can change in different cohorts of people aged over 65, ranging between 
35 and 60%. Moreover, 4 out 10 of pre-frail subjects used as test set 
reverted their status into ‘Non-Frail’ after one year. Figure 5.4 shows the 
presence of criteria in Italian pre-frail subjects, only 9 elderly had 2 
criteria, while 47 have only one objective or subjective criteria (25 and 22, 
respectively). The study has some weaknesses, such as the fact that the 
number of frail subjects is low, this is because finding frail individuals who 
fit the PRO-AGE project's inclusion and exclusion criteria is difficult. 




using standardized and accurate tools to study body composition, i.e. 






Table 5.1 | Anthropometric measures and BC markers of Italian Subjects 
BMI, body mass index; FM, fat mass; FMI, fat mass index; LM, lean mass; LMI, non-bone lean 
mass index; ALMI, non-bone appendicular lean mass index; SMI, skeletal mass index; BMC, 
bone mineral content; BMD, bone mineral density; Values are means ± SDs, unless otherwise 
stated. NS, not statistically significant. p-value (Fisher’s exact test and Kruskal - Wallis tests); 
Characteristics 
Non-Frail 
(N = 215) 
Pre-Frail 
(N = 56) 
Frail 
(N = 21) 
p-value 
Age (years) 71.4 ± 3.9 72.7 ± 3.7 74.1 ± 4.3 1.94e-03 
Female sex 99 (46.0) 41 (73.2) 18 (85.7) 1.43e-05 
Weight (kg) 74.5 ± 12.5 71.4 ± 12.6 78.9 ± 13.1 ns 
Height (cm) 165.0 ± 9.1 159.4 ± 8.4 154.2 ± 7.5 3.27e-05 
BMI (kg/m2) 26.9 ± 3.6 28.0 ± 4.6 32.8 ± 5.9 1.75e-02 
Waist circumference (cm) 93.4 ± 11.6 92.8 ± 10.8 101.9 ± 11.4 6.80e-03 
Hip circumference (cm) 101.0 ± 7.1 103.5 ± 8.9 112.3 ± 10.5 9.40e-04 
Waist to Hip circumference ratio 0.9 ± 0.1 0.9 ± 0.1 0.9 ± 0.1 ns 
Body Composition parameters     
FM (kg) 26.3 ± 7.2 27.7 ± 8.1 36.4 ± 8.7 9.54e-03 
FMI (kg/m2) 9.7 ± 2.9 11.1 ± 3.4 15.4 ± 4.3 3.54e-06 
FM/LM 0.59 ± 0.18 0.68 ± 0.2 0.90 ± 0.19 1.17e-06 
LM (kg) 45.7 ± 8.6 41.4 ± 7.7 40.5 ± 6.5 3.05e-04 
LMI (kg/m2) 16.6 ± 2.0 16.3 ± 2.1 17.0 ± 2.3 ns 
ALMI (kg/m2) 7.5 ± 1.1 7.2 ± 1.1 7.4 ± 1.2 ns 
SMI 0.27 ± 0.03 0.26 ± 0.03 0.23 ± 0.02 9.04e-07 
T-score -0.72 ± 1.1 -0.56 ± 1.27 -0.63 ± 1.2 ns 
BMC (g) 2500 ± 585 2274 ± 587 2024 ± 491 1.02e-04 
BMD (g/cm2) 1.07 ± 0.15 1.05 ± 0.16 1.03 ± 0.13 ns 
Android/Gynoid FM 0.67 ± 0.23 0.61 ± 0.2 0.65 ± 0.13 ns 
Android FM/LM 0.77 ± 0.27 0.84 ± 0.31 1.14 ± 0.22 2.78e-04 
Gynoid FM/LM 0.60 ± 0.23 0.71 ± 0.22 0.96 ± 0.24 8.22e-06 
VAT (g) 1587 ± 942 1409 ± 897 1815 ± 831 4.39e-03 
SAT (g) 1039 ± 453 1225 ± 524 1695 ± 736 1.07e-06 
l1 l4 T-score -0.83 ± 1.4 -0.85 ± 1.35 -0.40 ± 1.85 ns 




-1.37 ± 1.07 -1.68 ± 0.7 ns 




Table 5.2 | Anthropometric measures and BC markers of Italian Females 
BMI, body mass index; FM, fat mass; FMI, fat mass index; LM, lean mass; LMI, non-bone lean 
mass index; ALMI, non-bone appendicular lean mass index; SMI, skeletal mass index; BMC, 
bone mineral content; BMD, bone mineral density; Values are means ± SDs, unless otherwise 




(N = 99) 
Pre-Frail 
(N = 41) 
Frail 
(N = 18) 
p-value 
Age (years) 71 ± 4 73 ± 4 74 ± 4 4.60e-03 
Weight (kg) 66.8 ± 10.5 68.5 ± 10.8 76.9 ± 12.8 8.65e-03 
Height (cm) 157.9 ± 6.3 156.1 ± 6.2 152.8 ± 7.0 1.78e-02 
BMI (kg/m2) 26.4 ± 3.9 28.2 ± 4.9 32.7 ± 6.3 1.29e-04 
Waist circumference (cm) 86.7 ± 10.1 90.8 ± 10.4 99.8 ± 10.6 2.21e-05 
Hip circumference (cm) 101.4 ± 8.3 104.3 ± 8.5 112.4 ± 11.3 1.84e-04 
Waist to Hip circumference ratio 0.85 ± 0.07 0.87 ± 0.06 0.89 ± 0.08 ns 
Body Composition parameters     
FM (kg) 27.1 ± 7.6 28.9 ± 7.7 36.6 ± 9.2 3.46e-04 
FMI (kg/m2) 10.9 ± 3.1 11.97 ± 3.2 15.0 ± 4.51 2.34e-05 
FM/LM 0.71 ± 0.18 0.76 ± 0.17 0.94 ± 0.18 3.51e-05 
LM (kg) 37.8 ± 4.2 37.7 ± 3.8 38.5 ± 4.3 ns 
LMI (kg/m2) 15.2 ± 1.4 15.71 ± 2.01 16.6 ± 2.1 4.29e-03 
ALMI (kg/m2) 6.59 ± 0.80 6.83 ± 1.05 7.25 ± 1.09 1.28e-02 
SMI 0.25 ± 0.02 0.24 ± 0.02 0.22 ± 0.02 1.71e-04 
T-score -1.21 ± 0.97 -0.93 ± 1.11 -0.80 ± 1.09 ns 
BMC (g) 1982 ± 269 1987 ± 298 1862 ± 291 ns 
BMD (g/cm2) 0.96 ± 0.10 0.98 ± 0.10 0.99 ± 0.11 ns 
Android/Gynoid FM 0.51 ± 0.14 0.54 ± 0.15 0.62 ± 0.10 3.71e-03 
Android FM/LM 0.81 ± 0.29 0.90 ± 0.30 1.16 ± 0.23 3.31e-05 
Gynoid FM/LM 0.80 ± 0.19 0.81 ± 0.15 1.01 ± 0.23 6.86e-04 
VAT (g) 1073 ± 570 1206 ± 699 1470 ± 583 1.54e-02 
SAT (g) 1249 ± 451 1376 ± 508 2036 ± 774 1.35e-04 
l1 l4 T-score -1.49 ± 1.22 -1.19 ± 1.21 -0.58 ± 1.94 ns 
l1 l4 BMD (g/cm2) 1.00 ± 0.15 1.03 ± 0.14 1.11 ± 0.23 ns 
Neck T-score -1.57 ± 0.91 -1.53 ± 1.12 -1.69 ± 0.71 ns 




Table 5.3 | Urinary and Blood Markers of Italian Females 
Population based reference ranges for: RBC: 4.2-5.5 x10^3/ul; HGB: 13.0-16.5 g/dl; HCT: 
39.0-54.0 %; MCV: 82.0-99.0 fl; MCH: 27.0-32.0 pg; MCHC: 33.0-38.0 g/dl; WBC: 4.8-8.5 
x10^3/ul; Neutrophils: 2.0-7.5 x10^9/L; Lymphocytes: 1.0-4.0 x10^9/L; Monocytes: 0.2-
1.0 x10^9/L; Eosinophils: 0.0-0.5 x10^9/L; Basophils: 0.0-0.15 x10^9/L; Platelets: 130-
400 x10^3/ul; Glycated Haemoglobin: < 7.5%; Urinary Sodium: 50-250 (mmol/L); Urinary 
Potassium: 30-120 (mmol/L); Urinary Creatinine: D: 0.7-1.6 (g/24h); Urinary Urea:10-30 
g/24h; Urinary Nitrogen (g/24h): 10-35; Total Cholesterol: <200mg/dL; HDL: > 60mg/dL; 
LDL: <100 mg/dL; Triglycerides: <150 mg/dL; Glucose (serum): 60-110 mg/dL; Insulin: 2-
25 mcU/ml; PTH (serum): 10-70 pg/mL; p- value (Kruskal – Wallis test).  
 
Urinary and Blood Markers 
Non-Frail 
(N = 99) 
Pre-Frail 
(N = 41) 
Frail 




4.62 ± 0.33 4.64 ± 0.32 4.69 ± 0.32 ns 
HGB (g/dl) 13.54 ± 0.93 13.42 ± 0.94 13.06 ± 1.12 ns 
HCT (%) 42.06 ± 2.59 41.85 ± 2.56 40.71 ± 3.24 ns 
MCV (fl) 91.16 ± 3.60 90.36 ± 3.98 86.91 ± 6.80 2.62e-02 
MCH (pg) 29.34 ± 1.25 28.97 ± 1.32 27.88 ± 2.38 3.42e-02 
MCHC (g/dl) 32.18 ± 0.65 32.07 ± 0.70 32.16 ± 0.84 ns 
WBC (x10^3/ul) 5.44 ± 1.23 5.35 ± 1.25 6.83 ± 1.54 8.24e-04 
Neutrophils (x10^9/L) 3.02 ± 0.88 3.03 ± 1.00 4.11 ± 1.31 3.04e-03 
Lymphocytes (x10^9/L) 1.77 ± 0.49 1.67 ± 0.44 1.95 ± 0.48 ns 
Monocytes (x10^9/L) 0.48 ± 0.13 0.46 ± 0.13 0.53 ± 0.16 ns 
Eosinophils (x10^9/L) 0.15 ± 0.10 0.16 ± 0.08 0.17 ± 0.10 ns 
Basophils (x10^9/L) 0.03 ± 0.01 0.03 ± 0.02 0.04 ± 0.03 ns 
Platelets (x10^3/ul) 233.6 ± 49.4 230.4 ± 57.3 235.3 ± 53.3 ns 
Glycated Hemoglobin (%) 5.62 ± 0.34 5.76 ± 0.64 5.82 ± 0.87 ns 
Urinary Sodium (mmol/L) 72.1 ± 41.6 67.8 ± 32.4 74.6 ± 27.8 ns 
Urinary Potassium (mmol/L) 39.0 ± 26.8 37.0 ± 35.4 34.2 ± 8.8 ns 
Urinary Creatinine (g/24h) 0.95 ± 0.22 0.95 ± 0.23 0.90 ± 0.20 ns 
Urinary Urea (g/24h) 16.4 ± 4.3 15.9 ± 5.3 15.3 ± 4.2 ns 
Urinary Nitrogen (g/24h) 0.44 ± 0.20 0.42 ± 0.18 2.24 ± 0.98 4.84e-07 
Total Cholesterol (mg/dL) 208.5 ± 34.2 201.1 ± 28.1 194.7 ± 42.6 ns 
HDL (mg/dL) 61.8 ± 15.9 62.0 ± 11.9 58.2 ± 17.7 ns 
LDL (mg/dL) 125.6 ± 29.3 119.9 ± 29.4 121.4 ± 30.1 ns 
Triglycerides (mg/dL) 105.7 ± 46.2 95.8 ± 29.1 125.4 ± 54.3 ns 
Glucose (mg/dL) 99.7 ± 10.3 101.9 ± 15.6 109.2 ± 31.1 ns 
Insulin (mcU/ml) 8.9 ± 5.6 8.7 ± 5.2 10.8 ± 5.4 ns 




Figure 5.3 | Correlation Matrix based on Spearman's rank correlation. Orange circles highlights 




Table 5.4 | Multinomial logistic regression for the prediction of Pre-Frail and Frail status 
at baseline from BC and Urinary and Blood Markers.  









Pre-Frail (Intercept) -4.5e-01 6.9e-04 < 2.2e-16 ***  
 
  Age 8.4e-02 4.1e-02 0.04 * 1.09 (1.003; 1.180) 
  SAT 4.3e-04 4.0e-04 ns  1.00 
(0.999; 1.001) 
  MCV -7.8e-02 3.2e-02 0.02 * 0.92 (0.867; 0.986) 
  Urinary Nitrogen 5.1e-02 1.5e-01 ns  1.05 
(0.771; 1.436) 
Frail (Intercept) 6.1e-01 8.2e-04 < 2.2e-16 ***  
 
  Age 1.8e-01 6.9e-02 0.009 ** 1.20 (1.045; 1.374) 
  SAT 1.9e-03 6.0e-04 < 0.001 *** 1.00 (1.000; 1.003) 
  MCV -1.9e-01 5.6e-02 < 0.001 *** 0.82 (0.735; 0.918) 










Figure 5.4 | Frailty status distribution of Italian subjects and a focus on criteria in pre-
frail subjects. Subjective criteria include: unintentional weight loss (4.5 kg in the year 
before the evaluation), self-reported exhaustion and reduce energy consumption while 




 Sensibility (%) Specificity (%) 
Non-Frail 71 % 100 % 
Pre-Frail 0 % 74% 




6. FINAL REMARKS 
 
In this final chapter I wrap up the main conclusions of the three studies 
reported in this PhD work. As mentioned in Chapter 2, “Aims of the 
studies”, the main scientific questions I had try to answer were:  
- Is body composition in elderly across Europe different? Are there 
Body composition differences by sex? 
- Which are the inflammatory and metabolic markers associated with 
body composition in the elderly? 
- Which are the main differences of body composition and health 
markers that characterize frail individuals? Is there a BC “frailty 
signature”? 
The 1121 elderly participants to the European project NU-AGE have been 
thoroughly studied for their dietary intake (Berendsen et al., 2014) and 
their anthropometric, metabolic, physical and cognitive status (Santoro 
et al., 2014), in particular DXA scan was performed to evaluate their BC in 
terms of fat, lean and bone mass.  
Due to significant aging-related depletion of sex hormones such as rapid 
loss of estradiol and progesterone in women after menopause, it has 
been thought in the past that, as far as BC, women would become more 
similar to men as they get older. On the contrary, many results (Lauretta 
et al., 2017), including ours, demonstrate that there is a great difference 
among BC in elderly women and men. In fact, female aged 65 or more 
years old tend to have higher fat mass, in particular in the gynoid region, 
but lower lean and bone mass than males aged same. In addition, women 
and man are different in terms of bone content, in fact the prevalence of 
osteoporosis is higher in women. Our results showed also geographic 




the Netherlands, Poland, and the United Kingdom. The highest values of 
lean mass markers were reported for French subjects as respect to other 
countries. On the contrary, Polish participants have the higher values of 
fat mass markers while the highest value of bone mass markers is 
reported for Dutch elderly. These differences among the 5 countries 
could be attributed to genetic predisposition, dietary habits, lifestyle or 
physical activity, stress or education, because the criteria for exclusion 
and inclusion in the study were the same for all countries (Santoro et al., 
2014). After identifying through a cluster analysis six clusters for elderly 
males and five clusters for elderly females using the values of FM, FMI, 
LM, LMI, ALMI, FM/LM, SMI, t-score, BMC and BMD in addition to BMI, 
different metabolic parameters were compared across BC clusters. It is 
well known that an increase in fat mass, together with aging, can cause 
medical complications, such as hypertension, diabetes and cardiovascular 
disease. Even if the metabolic parameters are in the normal range, due to 
the exclusion and inclusion criteria of the project, differences between 
clusters emerged. In fact, subjects within the cluster with lowest BMI 
have the highest HDL cholesterol levels and the lowest triglycerides, 
glucose, insulin, HOMA, urea compared with the other clusters and 
females have the lowest level of diastolic pressure. At variance, the 
clusters with higher BMI have the lowest HDL cholesterol levels and the 
highest triglycerides, glucose, insulin, HOMA (IR and ) and urea and 
diastolic pressure (only females) levels compared with the other clusters. 
The similar levels of total cholesterol and LDL among the clusters may be 
explained by the fact that the number of subjects taking statins does not 
change among clusters. Additionally, subjects in cluster with highest 
values of LM markers have also highest values of handgrip strength.  
Moreover, it has been reported that an increase in fat mass is correlated 
with markers of inflammation among elderly (Brinkley et al., 2018; 




association between ghrelin and fat mass in females but not in males, 
while a positive association with SMI has been found in both genders. 
Leptin may play a role as a pro-inflammatory molecule in the setting of 
obesity (Matarese et al., 2005) along with resistin, whereas adiponectin 
and ghrelin have anti-inflammatory properties. Leptin is an adipokine 
secreted by adipocytes, generally increases with weight gain, and 
decreases with weight loss (Spiegelman BM and Flier JS, 2001), but it has 
been demonstrated that leptin is also produced by skeletal muscle 
(Fernández-Real et al., 2000; Wolks et al., 2012) as well as bone cells 
(Thomas T, 2004) in fact a significant positive association between fat 
mass, lean mass and bone mass markers and leptin levels has been found 
in our study. However, our results concord with a recent paper by Baker 
and colleagues demonstrating that in the elderly high serum levels of 
adiponectin are significantly correlated with low BMI, fat and lean mass 
BC markers (Baker et al., 2018)(Baker et al., 2018)(Baker et al., 
2018)(Baker et al., 2018). Moreover, in males and females’ clusters 
adiponectin levels decrease as BMI increases. However, it is interesting 
to note that among the five clusters of females, the two clusters with 
similar BMI (25.09 and 26.62 respectively) have different adiponectin 
levels, those with higher levels are in the overweight group also 
characterized by higher levels of fat and bone mass and lower levels of 
lean mass. A similar result is found among the two low obesity clusters 
(BMI 31.48 and 31.92 respectively) even if it is not significant. 
At variance, the only significant difference of adiponectin levels among 
the six male clusters is found between the low obesity B and the normal 
weight clusters which have higher levels. A similar trend also emerged 
when comparing the two clusters (overweight A vs B and low obesity A vs 
B) with similar BMI but different amount of fat, lean and bone mass.  
Regarding inflammatory markers, a significant positive correlation 




association with SMI in both females and males. CRP and AGP are 
positively correlated with lean mass markers in female. In addition, AGP 
is positively correlated LMI and negatively associated with SMI in female, 
while in male the only significant association between AGP levels and BC 
markers is a positive correlation with android/gynoid FM ratio. Different 
studies had demonstrated an association between the specific pattern of 
increased CRP and decreased albumin concentrations with sarcopenia, 
frailty and vascular and non-vascular mortality in elderly subjects (Clarke 
et al., 2008; Hubbard et al., 2009). Even if no correlation has been found 
between BC markers and indexes and circulating levels of a series of pro- 
and anti-inflammatory molecules such as IL6, Pentraxin 3, IL10, TGFβ1, 
TNFα, IL6rα, gp130, TNFαR1 and TNFαR2, there are evidence that there 
are associations between fat mass, BMI and waist circumference and 
inflammatory markers (Brinkley et al., 2012; Schrager et al., 2007; Cesari 
et al., 2005). 
Finally, a focus on the Italian population was carried out in 271 healthy 
non-frail and pre-frail elderly who participated in the European project 
NU-AGE and 21 frail participants of the PRO-AGE project. The prevalence 
of frailty is higher in women when compared with men (9,1 % and 6.0%, 
respectively) (Manfredi et al., 2019), considering that the results of our 
study confirm these findings, i.e. Frail group is represented for the 85.7% 
of female subjects, we decided to analyze females apart. 
As expected, major differences exist between BC characteristics in elderly 
frails. Frail women have higher LMI values than the other two groups, this 
may be due to the fact that this group have a higher weight than non-frail 
or pre-frail women. In fact, despite higher values of LMI, the ratio of FM 
to LM turns out to be significantly higher in frail elderly women. 
Moreover, the frail group have significantly lower level of SMI, which 
represents a marker of sarcopenia (Kim et al., 2016; Guglielmi et al., 




associated with health risk and disability than individual conditions 
(Roubenoff et al., 2004). SAT and VAT were correlated with multiple 
metabolic risk factors (Fox et al., 2007), as expected our results reported 
high level of VAT and SAT for the frail group, in addition SAT seems to be 
a valid predictor of frailty in elderly female. Low levels of haemoglobin 
are often associated with low muscle strength or fatigue in frail 
individuals (Roy et al., 2011), although no significant difference emerged, 
frail individuals have the lowest values. In addition, it has been 
demonstrated that Frailty is associated with higher numbers of 
neutrophils and monocytes in both males and female (Samson et al., 
2019), in accordance with our results. 
In conclusion, the results presented in this study provide a synthesis of 
the health status of elderly subjects in Europe that can be used as a 
reference for studies related to gender differences in body composition, 
disease conditions, and differences between European countries. The 
study has some weaknesses, such as the fact that the subjects are healthy 
volunteers, highly educated and interested in nutrition and health issues 
and therefore may not be representative of the population of the same 
age. In addition, the last part of the study (on frailty) has a low sample 
size, due to the fact that only Italian women were analyzed. The main 
strength is constituted by the use of a standardized and accurate method 
as DXA was performed at European level to assessed BC composition, as 
well as the availability of a high number of parameters per each subject 
yielding data of a high quality. 
As a whole, this work indicated the importance of BC in the aging process, 
however, as we focused mainly on healthy volunteers and only in the last 
part of the study we included a certain number of people with signs of 
frailty, the conclusions could underestimate the importance of BC 




by elevated inflammaging), therefore this warrants future studies that 
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